EurekaMag.com logo
+ Translate

Biology, Geography & Health: Chapter 31640

Chapter 31640 provides bibliographic information on scholary research in the basic and applied life, earth and health sciences.



Seong, C.; Lee, S.; Im, S.; Nam, E.; Yoo, E.; Lee, H.; Lee, S. Y.; Kim, D.; Lee, S. N.; Moon, I.; Chung, W. S., 1998: HLA-identical peripheral blood progenitor cells transplantation for metastatic gastric carcinoma using non-myeloablative conditioning regimen

Gale, R. P.; Butturini, A.; Horowtiz, M. M., 1995: HLA-identical sibling bone marrow transplants for acute lymphoblastic leukemia

Michallet, M.; Archimbaud, E.; Bandini, G.; Rowlings, P.; Horowitz, M.; Gratwohl, A., 1993: HLA-identical sibling bone marrow transplants for chronic lymphocytic leukemia A collaborative study of the European Bone Marrow Transplantation Group and International Bone Marrow Transplantation Registry


Szer, J.; Grigg, A.; Lee, D.; Bardy, P., 1998: HLA-identical sibling peripheral blood cell transplants The Australian experience and preliminary results of a randomised study

Dong, Rui Ping; Kimura, Akinori; Numano, Fujio; Nishimura, Yasuharu; Sasazuki, Takehiko, 1992: HLA-linked susceptibility and resistance to Takayasu arteritis

Yazdovskii, V. V.; Voronin, A. V.; Poroshina, Yu A., 1998: HLA-markers of severe atopic syndrome

Xiao, Lulu; Zhang, Sheng; Ye, Xin; Ma, Linya; Zhu, Weiguo, 1996: HLA-mismatched cord blood transplantation in leukemia

Mcguirk, Joseph P.; Seropian, Stuart; Cooper, Dennis, 1998: HLA-mismatched family donor transplants A novel strategy as curative therapy for patients with hematologic disorders

Lau, Y. L.; Lee, A. C. W.; Chan, C. F.; Chiu, E. K. W.; Jones, B. M.; Liang, R. H. S.; Chan, T. K.; Yeung, C. Y., 1993: HLA-non-identical T-cell depleted bone marrow transplantation for severe combined immunodeficiency

Ogg, Graham S.; Mcmichael, Andrew J., 1998: HLA-peptide tetrameric complexes

Lintsov, A.; Barabanova, E.; Soliev, A.; Yemelyanov, A.; Genter, E.; Mikhelson, V., 1998: HLA-phenotype and deoxyribonucleic acid repair capacity of lymphocytes in asthmatic patients

Barabanova, E.; Linotsv, A.; Soliev, A.; Uslontsev, B., 1994: HLA-phenotype and effect of thymic hormone preparation in patients with bronchial asthma

Bondarenko, A. L., 1997: HLA-phenotype in the estimation of the risks factors of bronchial asthma

Serebryanaya, N. B.; Novik, A. N.; Katkova, I. V.; D'yakova, V. V.; Snetkova, I. G.; Voloshin, S. V.; Zhiburt, E. B., 1998: HLA-phenotype of patients with non-Hodgkins lymphoma and cytokine status

Tilmann, H. L.; Chen, D. F.; Boeker, K.; Trautwein, C.; Kubicka, S.; Endres, W.; Kliem, V.; Robin Winn, M.; Pastucha, L. T.; Manns, M. P.; Stangel, W., 1996: HLA-phenotypes in patients suffering from HCV induced end-stage liver cirrhosis with and without hepatocellular carcinoma requiring transplantation

Khaitov, R. M.; Akopyan, A. V.; Polyanskaya, I. S.; Alekseev, L. P., 1993: HLA-profile of Armenian populations

Kunstmann, E.; Epplen, C.; Elitok, E.; Suerbaum, S.; Epplen, J. T.; Schmiegel, W. H., 1997: HLA-region genes as predisposing factors for a H pylori infection

Zanni, Martin P.; Von Greyerz, Salome; Schnyder, Benno; Brander, Karl A.; Frutig, Karin; Hari, Yvonne; Valitutti, Salvatore; Pichler, Werner J., 1998: HLA-restricted, processing- and metabolism-independent pathway of drug recognition by human alphabeta T lymphocytes

Dine, Gerard; Oudin, Michel; Bourguignat, Laurent; Montagnac, Richard, 1996: HLA-specific antibody detection by ELISA may prevent undesired hyper-immunisation of kidney patients by blood transfusions

Turesson, C.; Jacobsson, L.; Bergstrom, U.; Truedsson, L.; Sturfelt, G., 1998: HLA-subtypes have limited impact on the risk of extra-articular manifestations in rheumatoid arthritis

Tumer, Necmiye; Ekim, Mesiha; Yalcinkaya, Fatos; Cakar, Nilgun; Ensari, Cuneyt, 1995: HLA-system and the frequency of relapses in childhood minimal change nephrotic syndrome in Turkish children

Bondarenko, Alla, 1996: HLA-system and viral hepatitis B in juveniles

Sakaguchi, Jun; Takeshita, Mikihiko; Kagawa, Mizuo; Izawa, Masahiro; Takakura, Kintomo, 1994: HLA-type of cerebral vasospasm patients after aneurysmal subarachnoid hemorrhage

Polzot Martin, I.; Mercier, P.; Coso, D.; Vollot, F.; Gastaut, A., 1993: HLA-typing in HIV infected caucasian patients with sulfonamides allergy

Clark, Michelle; Duane, D. D., 1995: HLA-typing in three families with two generations of concurrent hypersomnia and attention deficit disorder

Sastre Garau, X.; Loste, M. N.; Lepage, V.; Rozan, S.; Validire, P.; Vincent Salomon, A.; Zafrani, B.; De La Rochefordiere, A.; Durand, J. C.; Charron, D., 1996: HLAB1*DR13 frequency decreased in cervical carcinoma

Pachman, L. M.; Goronzy, J. J.; Miller, M. L.; Liotta, M.; Mendez, E.; Weyand, C. M., 1997: HLADRB1 antigens in children with symptoms of systemic onset juvenile rheumatoid arthritis

Tzeng, S.F.; Bresnahan, J. C.; Beattie, M. S.; De Vellis, J., 1998: HLH ID gene family expression in neural cells of the rat spinal cord following contusion injury

Skogberg, M.; Meyer, K.; Pettersson, S., 1995: HLH proteins contribute to IgH gene expression in late B-cell differentiation

Henter, Jan Inge; Arico, Maurizio; Egeler, R. Maarten; Elinder, Goran; Favara, Blaise E.; Filipovich, Alexndra H.; Gadner, Helmut; Imashuku, Shinsaku; Janka Schaub, Gritta; Komp, Diane; Ladisch, Stephan; Webb, David, 1997: HLH-94 A treatment protocol for hemophagocytic lymphohistiocytosis

Marintchev, L. M.; Naumova, E. J.; Rashkov, R. K.; Arnett, F. C.; Reveille, J. D., 1995: HLOA class II alleles and autoantibodies in Bulgarians with systemic lupus erythematosus

Roy, A. M.; Taylor, L.; Garcia, Z.; Coleman, J., 1993: HLP-I, is involved in targeting and assembly of outer membrane proteins Escherichia coli

Bonis, J.; Preux, P. M.; Nzisabira, L.; Letenneur, L.; Muhirwa, G.; Buzingo, T.; Kamuragiye, A.; Preux, C.; Ngoga, E.; Dumas, M.; Denis, F., 1994: HLTV-I in Burundi Lack of reactivity to the HTLV-I immunodominant envelope epitope

Tsuchiya, N.; Yamaguchi, A.; Mitsui, H.; Shiota, M.; Ogawa, A.; Tokunaga, K.; Juji, T.; Ito, K., 1995: HLa-B39 may confer susceptibility to seronegative spondylarthropathies in Japan A support for arthritogenic peptide theory?

Xu, Y.; Corkin, S., 1996: HM revisits the tower of Hanoi puzzle

Postle, B. R.; Corkin, S., 1994: HM shows impaired word-stem completion priming with novel words

Smith, Harriet O.; Stephens, Nicole D.; Sarto, Gloria E.; Genesen, Mark C.; Dorin, Maxine H.; Griffith, Jeffrey K., 1998: HM-CSF in human primary endometrial cell cultures Effects of substrate, media, passage, and coculture with fibroblasts

Bonetti, M. G.; Ciritella, P.; Valle, G.; Scarabino, T., 1992: HM-PAO SPECT diagnosis of brain death

Sadee, W.; Moro, O.; Lameh, J., 1993: HM1 receptor internalization induced by carbachol requires a short S/T rich domain of the i3 loop

Kelner, M. J.; Morris, T. C.; Taetle, R., 1997: HMAF has antitumor activity in the mdr1/gp170-positive human MV522 metastatic lung carcinoma xenograft

Batchev, C. J.; Amin, M. B.; Lee, M. W.; Linden, M. D.; Torres, F. X.; Tetu, B.; Ro, J. Y.; Gown, A.; Zarbo, R. J., 1995: HMB-45 immunoreactivity in renal angiomyolipomas True vs false positive immunostaining with ultrastructural correlations

Yates, A. J.; Banerjee, S. S.; Bishop, P. W.; Graham, K. E., 1993: HMB-45 in non-melanocytic tumours

Pena, J. R.; Turbat Herrera, E. A.; Shultz, J. J.; Kelly, D. R.; Herrera, G. A., 1993: HMB-45 is not an absolutely specific pre-melanosome associated antigen

Holland, T. T.; Gagnier, J. M.; Skelton, H. G.; Smith, K. J.; Lupton, G. P., 1992: HMB-45 positivity in non-melanocytic tumors

Bonsib, S. M., 1996: HMB-45 reactivity in renal smooth muscle neoplasms

Skelton, H. G.; Smith, K. J.; Maceira, J.; Lupton, G. P., 1992: HMB45 negative spindle cell melanoma

Bonetti, F.; Chiodera, P. L.; Pea, M.; Martignoni, G.; Zamboni, G.; Caneva, A.; Mombello, A.; Mariuzzi, G. M., 1996: HMB45-immunoreactivity in pulmonary lesions Diagnostic usefulness and pitfalls

Siegel, D.; Tang, B.; Feinman Siegel, R.; Teitz, T.; Richon, V.; Rifkind, R. A.; Marks, P. A.; Michaeli, J., 1997: HMBA and related compounds induce apoptosis in human myeloma cells

Prasad, G. L.; Cooper, H. L., 1998: HME1 nucleic acids and probes

Wang, S.; Robert, M.F.; Fontaine, G.; Duncan, A.; Schappert, K.; Nadeau, J. H.; Johnson, K. R.; Zietkiewicz, E.; Hruz, P., 1992: HMG CoA Lyase Characterization of a mouse liver cDNA and chromosomal mapping in human and mouse

Chou, C.; Chuang, C.; Roehrig, K., 1995: HMG CoA inhibits ATP citrate lyase in smooth muscle cells

Mitchell, Grant A.; Robert, Marie France; Fontaine, Gisele; Wang, Shupei; Beauchemin, Michel; Miziorko, Henry; Gibson, Mike, 1993: HMG CoA lyase Characterization of human genomic clones and a cluster of mutations in hereditary HL deficiency

Robert, M.F.; Roberts, J. R.; Ashmarina, L.; Narasimhan, C.; Poitier, E.; Wang, S.; Gibson, M.; Ozand, P.; Wanders, R.; Miziorko, H.; Mitchell, G., 1994: HMG CoA lyase Mutation detection and development of a bacterial expression system for screening the activity of mutant alleles from HL-deficient patients

Wang, S. P.; Marth, J.; Oligny, L.; Vachon, M.; Robert, M.F.; Mitchell, G. A., 1995: HMG CoA lyase Targeted gene disruption in mice causes prenatal lethality in homozygotes

Mitchell, G. A.; Robert, M.F.; Fontaine, G.; Wang, S.; Lambert, M.; Cole, D.; Lee, C.; Gibson, M.; Miziorko, H., 1992: HMG CoA lyase deficiency Detection of a causal mutation in an affected French-Canadian sibship

Oligny, L. L.; Vachon, M.; Wang, S. P.; Marth, J.; Robert, M.F.; Mitchell, G. A., 1996: HMG CoA lyase deficiency is lethal in the embryonic stage of murine development

Nabeshima, Kunihiro; Yoshimura, Ashio; Inui, Kiyoko; Uda, Susumu; Sugenoya, Yoichi; Ideura, Terukuni, 1994: HMG CoA reductase inhibitor suppresses initial macrophage infiltration and PDGF-induced mesangial cell proliferation in rats with mesangial proliferative nephritis in vivo

Feussner, Giso, 1994: HMG CoA reductase inhibitors

Alvarez Sala, L. A.; Horcajada, C.; Alonso, R.; Porres, A.; Montoya, M. T.; Blazquez, E.; Falcon, L.; Gomez Gerique, J. A.; Mata, P.; De Oya, M., 1993: HMG CoA reductase inhibitors do not alter adrenal cortisol secretion nor functional reserve, neither sexual hormone levels

Lozano, L.; Tornero, F.; Uson, J.; Rincon, B.; Garzon, A.; Roldan, A., 1994: HMG CoA reductase inhibitors in hemodialysis patients; A risk factor for acute pancreatitis?

Kolyada, A. Y.; Madias, N. E., 1996: HMG CoA reductase inhibitors induce apoptosis in rat aortic vascular-smooth-muscle cells

Zhao, Yufen; Cheng, Wenjie; Gibb, Corinne L. D.; Gupta, Goutam; Kallenbach, Neville R., 1996: HMG box proteins interact with multiple tandemly repeated n m DNA sequences

Billings, P. C.; Lawrence, D. L.; Cryer, J. E.; Engelsberg, B. N., 1994: HMG boxes 1 and 2 are required for high affinity binding of high mobility group protein 2 to cisplatin-damaged DNA

Grosschedl, Rudolf; Giese, Klaus; Pagel, John, 1994: HMG domain proteins Architectural elements in the assembly of nucleoprotein structures

Turunen, A.M.; Linnala Kankkunen, A.; Mahonen, A.; Maenpaa, P. H., 1996: HMG-2 protein participates in the negative regulation of human PTH gene mediated by 1,25-dihydroxyvitamin D

Vickers, S., 1995: HMG-COA reducatase inhibitor metabolites

Ashmarina, L. I.; Miziorko, H.; Rusnak, N.; Mitchell, G., 1994: HMG-CoA lyase Demonstration of peroxisomal localization and possible implications for HMG CoA metabolism and hereditary HL deficiency in humans

Wang, S.; Robert, M.F.; Marth, J.; Gibson, M.; Wanders, R.; Schwartz, R.; Mitchell, G. A., 1994: HMG-CoA lyase gene Cloning and characterization of the 5 end of the mouse gene, gene targeting in ES cells, and demonstration of large deletions in three HL-deficient patients

Smythe, Cheryl D. W.; Kealey, Terence, 1996: HMG-CoA reductase activity and regulation in the isolated human apocrine and sebaceous glands

Smythe, C. D. W.; Kealey, T., 1996: HMG-CoA reductase activity and regulation in the isolated human hair follicle

Woodgate, L. J.; Walker, E. J.; Gilkes, A. F.; Walsh, V.; Sweeney, M. C.; Mills, K. I.; Burnett, A. K., 1998: HMG-CoA reductase as a target for therapy in leukaemia

Woodgate, L. J.; Walker, E. J.; Mills, K. I.; Burnett, A. K., 1997: HMG-CoA reductase expression is related to ATR responsiveness in the myeloid HL60 cell line

Bochar, D. A.; Brown, J. R.; Doolittle, W. F.; Klenk, H.P.; Lam, W.; Schenk, M. E.; Rodwell, V. W., 1996: HMG-CoA reductase from the thermophilic archaeon Sulfolobus solfatericus

Little, Peter J.; Dinatale, Angela; Neylon, Craig B.; Bobik, Alex, 1993: HMG-CoA reductase inhibition by simvastatin depletes membrane-bound heterotrimeric G proteins and inhibits proliferation of vascular smooth muscle cells

Yuki, T.; Adachi, H.; Yoshizawa, T.; Kawaguchi, T.; Ogihara, T.; Miyazaki, A.; Matanabe, S.; Sato, N., 1995: HMG-CoA reductase inhibition improved alcoholic liver disease

Yuki, T.; Yoshizawa, T.; Adachi, Y.; Kawaguchi, T.; Ogihara, T.; Komada, T.; Watanabe, S.; Kitami, N.; Sato, N., 1995: HMG-CoA reductase inhibitor improved liver function tests of continuously drinking patients with or without HCV infection

Sung, Bong H.; IzzoJoseph L.Jr.; Orlowski, Wendy; Bateson, Mary K.; Wilson, Michael F., 1994: HMG-CoA reductase inhibitor improves exaggerated blood pressure response to mental stress in normotensives with hypercholesterolemia

Kagami, Shin-Ichiro; Kanari, Hiroko; Suto, Akira; Fujiwara, Michio; Ikeda, Kei; Hirose, Koichi; Watanabe, Norihiko; Iwamoto, Itsuo; Nakajima, Hiroshi, 2008: HMG-CoA reductase inhibitor simvastatin inhibits proinflammatory cytokine production from murine mast cells

Nabeshima, Kunihiro; Inui, Kiyoko; Uda, Susumu; Sugenoya, Youichi; Iwasaki, Shigeki; Ideura, Terukuni; Yoshimura, Ashio, 1997: HMG-CoA reductase inhibitor suppression of glomerular cell proliferation in rats with anti-Thy-11 nephritis

Lintott, Caroline J.; Scott, Russell S., 1992: HMG-CoA reductase inhibitor use in the aged A review of clinical experience

Halkin, Amir; Lossos, Izidore S.; Mevorach, Dror, 1996: HMG-CoA reductase inhibitor-induced impotence

Mol, Marc J. T. M.; Stalenhoef, Anton F. H., 1993: HMG-CoA reductase inhibitors

Davignon, Jean; Montigny, Martine; Dufour, Robert, 1992: HMG-CoA reductase inhibitors A look back and a look ahead

Larsson, Olle, 1996: HMG-CoA reductase inhibitors Role in normal and malignant cells

Harper, Cynthia M.; Fyfe, Alistair I., 1997: HMG-CoA reductase inhibitors block multiple events in atherogenesis

Bernini, Franco; Bellosta, Stefano; Canavesi, Monica; Fumagalli, Remo, 1996: HMG-CoA reductase inhibitors in the control of lipid metabolism in macrophages

Fyfe, Alistair I.; Harper, Cynthia M., 1995: HMG-CoA reductase inhibitors inhibits activated monocyte/macrophage surface expression of class I and II HLA molecules

Rudich, S. M.; Mongini, P. K. A.; Perez, R. V.; Katznelson, S., 1998: HMG-CoA reductase inhibitors pravastatin and simvastatin inhibit human B-lymphocyte activation

Laufs, Ulrich; Liao, James K., 1998: HMG-CoA reductase inhibitors prevent inhibition of Gi-proteins by oxidized low-density lipoprotein

Laufs, U.; Endres, M.; Huang, P. L.; Moskowitz, M. A.; Liao, J. K., 1998: HMG-CoA reductase inhibitors reduce cerebral infarct size by upregulating endothelial nitric oxide synthase

Korth, Kenneth L.; Dixon, Richard A.; Stermer, Bruce A., 1995: HMG-CoA reductase is differentially regulated in potato foliage by insect herbivory and mechanical injury

Koning, A. J.; Wright, R. L., 1995: HMG-CoA reductase isozymes are differentially localized and induce the proliferation of distinct ER subdomains when expressed at increased levels in S cerevisiae

Chun, K.; Miziorko, H. M., 1998: HMG-CoA synthase Identification of E95 as a catalytic residue

Kriatchko, Aleksei, N.; Bergeron, Serge; Swanson, Patrick, C., 2008: HMG-box domain stimulation of RAG1/2 cleavage activity is metal ion dependent

Boettger, M.; Arnold, W.; Zaitsev, S.; Vorob'ev, V. I.; Haberland, A.; Schimke, I., 1996: HMG1-effected gene transfer using cell cultures and tissue explants xenografted in immunodeficient mice

Oikarinen, Jouko; Tarkka, Tatu; Raatikainen, Elina; Friman, Sanna; Mannermaa, Riitta Maaria, 1994: HMG17-chromatosome is an ATP/ADP binding structure similar to actin

Cramer, C. L.; Weissenborn, D. L., 1997: HMG2 promoter expression system

Manabe, Takayuki; Ohe, Kenji; Katayama, Taiichi; Matsuzaki, Shinsuke; Yanagita, Takeshi; Okuda, Hiroaki; Bando, Yoshio; Imaizumi, Kazunori; Reeves, Raymond; Tohyama, Masaya; Mayeda, Akila, 2007: HMGA1a sequence-specific RNA-binding factor causing sporadic Alzheimers disease-linked exon skipping of presenilin-2 pre-mRNA

Malek, Anastasia; Bakhidze, Elena; Noske, Aurelia; Sers, Christine; Aigner, Achim; Schaefer, Reinhold; Tchernitsa, Oleg, 2008: HMGA2 gene is a promising target for ovarian cancer silencing therapy

Chiappetta, Gennaro; Ferraro, Angelo; Vuttariello, Emilia; Monaco, Mario; Galdiero, Francesca; De-Simone, Veronica; Califano, Daniela; Pallante, Pierlorenzo; Botti, Gerardo; Pezzullo, Luciano; Pierantoni, Giovanna-Maria; Santoro, Massimo; Fusco, Alfredo, 2008: HMGA2 mRNA expression correlates with the malignant phenotype in human thyroid neoplasias

Di-Cello, Francescopaolo; Hillion, Joelle; Hristov, Alexandra; Wood, Lisa, J.; Mukherjee, Mita; Schuldenfrei, Andrew; Kowalski, Jeanne; Bhattacharya, Raka; Ashfaq, Raheela; Resar, Linda, M. S., 2008: HMGA2 participates in transformation in human lung cancer

Klune, John, R.; Dhupar, Rajeev; Cardinal, Jon; Billiar, Timothy, R.; Tsung, Allan, 2008: HMGB1 Endogenous danger signaling

Topalova, Dessislava; Ugrinova, Iva; Pashev, Thya, G.; Pasheva, Evdokia, A., 2008: HMGB1 protein inhibits DNA replication in vitro A role of the acetylation and the acidic tail

Zhou, Zheng; Han, Jun-Yan; Xi, Cai-Xia; Xie, Jian-Xin; Feng, Xu; Wang, Cong-Yi; Mei, Lin; Xiong, Wen-Cheng, 2008: HMGB1 regulates RANKL-induced osteoclastogenesis in a manner dependent on RAGE

Rossini, Alessandra; Zacheo, Antonella; Mocini, David; Totta, Pierangela; Facchiano, Antonio; Castoldi, Raffaella; Sordini, Paolo; Pompilio, Giulio; Abeni, Damiano; Capogrossi, Maurizio, C.; Germani, Antonia, 2008: HMGB1-stimulated human primary cardiac fibroblasts exert a paracrine action on human and murine cardiac stem cells

IImura, O.; Vrtovsnik, F.; Terzi, F.; Friedlander, G., 1996: HMGCoA reductase inhibitors induce apoptosis in mouse proximal tubular cells in primary culture

Castelao, A. M.; Grino, J. M.; Andres, E.; Gilvernet, S.; Seron, D.; Castineiras, M. J.; Roca, M.; Calceran, J. M.; Gonzalez, M. T.; Alsina, J., 1993: HMGCoA reductase inhibitors lovastatin and simvastatin in the treatment of hypercholesterolemia after renal transplantation

Feizo, M. Schoenberg; Ashar, H.; Tkachenko, A.; Fletcher, J. A.; Weremowicz, S.; Yoon, S.J.; Krauter, K. S.; Kucherlapati, R.; Chada, K.; Morton, C. C., 1995: HMGI-C An architectural factor at 12q14-15 involved in frequent chromosomal rearrangement in benign tumors

Quade, B. J.; Williams, A. J.; Collins, T.; Nowak, R. A.; Morton, C. C., 1997: HMGI-C and HMGI expression in uterine leiomyomata Dysregulation of architectural factors in a benign neoplasm

Chakarov, S.; Chakalova, L.; Tencheva, Z.; Angelova, A., 1995: HMGI/Y chromosomal proteins in developing rat brain cells

Chao, Chia-Chia; Shieh, Jeffrey; Kuo, Sheng-Chu; Wu, Bor-Tsang; Hour, Mann-Jen; Leung, Yuk-Man, 2008: HMJ-53A accelerates slow inactivation gating of voltage-gated K+ channels in mouse neuroblastoma N2A cells

Hemmi, H.; Zhong, X.L.; Kanazawa, S.; Koike, J.; Iwasaki, K.; Yamada, K.; Takano, S.; Tsujita, K.; Yanagita, K.; Yoshio, T.; Shimatake, H., 1998: HMLH1 and hMSH2 protein expression in sporadic colorectal cancer

Esteller, Manel; Levine, Ross; Baylin, Stephen B.; Ellenson, Lora Hedrick; Herman, James G., 1998: HMLH1 promoter hypermethylation is associated with the microsatellite instability phenotype in sporadic endometrial carcinomas

Watanabe, Y.; Nishio, M.; Hidaka, H., 1998: HMN-1180, a novel selective nNOS inhibitor, and its structure-activity relationship

Nishio, Masahiro; Watanabe, Yasuo; Hidaka, Hiroyoshi, 1998: HMN-1180, a specific small molecule inhibitor of neuronal nitric oxide synthase

Katoh, F.; Honmura, T.; Yamaguchi, R.; Matsuda, M.; Kimura, K.; Hidaka, H., 1997: HMN-214, a novel antitumor sulfonamide compound

Katoh, F.; Matsuda, M.; Fujita, F.; Fujita, M.; Kimura, K.; Hidaka, H., 1997: HMN-214, a novel sulfonamide anti cancer compound

Philbin, Edward F.; Jenkins, Paul L.; Nichols, Melissa; Di Salvo, Thomas G., 1997: HMO management of congestive heart failure Resource use, process of care and clinical outcomes

Schectman, J. M.; Elinsky, E. G.; Kanwal, N. K., 1994: HMO physician attitudes toward drug cost containment strategies

Pearson, S. D.; Salem Schatz, S.; Rucker, M.; Orav, E. J.; Pedan, A., 1995: HMO physician correlates of referral for acute low back pain

Carlson, L. G.; Schectman, J. M.; Elinsky, E. G., 1994: HMO provider attitude toward guideline implementation for diabetic care

Kirschner, P. B.; Wei, J. Y., 1996: HMOs and the elderly Focus on Boston

Minko, T.; Kopeckova, P.; Pozharov, V.; Omelyanenko, V.; Kopecek, J., 1998: HMPA copolymer bound adriamycin does not induce multidrug resistance in a human ovarian carcinoma cell line

Rihova, Blanka; Srogl, Jan; Jelinskova, Marketa; Hovorka, O.; Buresova, Magda; Subr, Vladimir; Ulbrich, Karel, 1997: HMPA-based biodegradable hydrogels containing different forms of doxorubicin Antitumor effects and biocompatibility

Jacobson, M. P.; Sperling, M. R.; Cone, L.; Brooks, M.; Saykin, A. J., 1992: HMPAO SPECT Assessment of brain inactivation during the Wada test

Hornig Rohan, M.; Mozley, P. D.; Amsterdam, J. D., 1994: HMPAO SPECT brain imaging in treatment-resistant depression

Deutsch, G.; Mountz, J. M.; Chatterjee, A., 1994: HMPAO SPECT identifies cortical diaschisis effects of white matter lesions in dementia

Bell, K. M.; Widmark, C.; Demet, E.; Milne, N., 1994: HMPAO SPECT identifies schizophrenic patients with stimulant abuse

Baird, A. E.; Donnan, G. A.; Austin, M.; Mckay, W. J., 1992: HMPAO SPECT measurement of reperfusion after thrombolytic therapy in acute stroke

Vera, P.; Rohrlich, P.; Stievenart, J. L.; Bonnin, F.; Buyck, D.; Hassan, M.; Vilmer, E.; Bok, B., 1996: HMPAO SPECT scan abnormalities in children receiving cytarabine high dose

Fawdry, R.; Gruenewald, S. M.; Sommerville, E., 1992: HMPAO SPECT scans in epilepsy

Gruenewald, S. M.; Fawdry, R.; Anderson, J.; Gordon, E. , 1992: HMPAO SPECT scans in normal volunteers and unmedicated schizophrenics

Levy, P.; Kerita, H.; Edeline, V.; Vilgrain, V.; Belghiti, J.; Bernades, P., 1993: HMPAO Tc99m leukocyte scintigraphy is useful for the diagnosis of infected pancreatic necrosis

Brodie, Martin J.; Duncan, Susan; Gillen, Gerard, 1992: HMPAO and iomazenil SPECT scanning in patients with refractory symptomatic epilepsy

Sabri, O.; Erkwoh, R.; Kaiser, H. J.; Buell, U.; Sass, H., 1995: HMPAO brain SPECT and psychopathology in schizophrenic patients Comparison of unmedicated acute and with neuroleptics treated patients

Haindl, W.; Frater, C. J.; Sachdev, P. S.; Brodaty, H., 1992: HMPAO brain scanning with SPECT in patients with dementia

Levy, P.; Kerita, H.; Edeline, V.; Vilgrain, V.; Belghiti, J.; Bernades, P., 1993: HMPAO technetium-99m leukocyte scintigraphy is useful for the diagnosis of infected pancreatic necrosis in alcoholic chronic pancreatitis

Modiest, Elaine; Swartz, Barbara E.; Uszler, J. Michael; Walsh, Gregory; Mandelkern, Mark M., 1995: HMPAO-SPECT VS 18FDG-PET imaging in a community hospital CCTV-EEG unit

Podreka, I.; Fischer, G.; Diamant, K.; Schneider, C.; Brucke, T.; Kasper, S., 1995: HMPAO-SPECT findings in opiate dependent subjects

Saxena, P.; Pavel, D.; Quintana, J. C.; Tom, M.; Hier, D., 1998: HMPAO-SPECT imaging of dementias A new method for enhancing its usefulness using whole volume evaluation and a special scaling

Morelec, I.; Perrin Fayolle, O.; Leprince, E.; Francois, Y.; Descos, L.; Bonmartin, A., 1995: HMPAO-Tc99m marked polynuclear scintigraphy One exam, one patient, three complications from Crohns disease

Goegelein, H.; Schoelkens, B. A.; Englert, H. C., 1998: HMR 1883 - A novel KATP blocker with improved selectivity for heart muscle cells

Billman, George E.; Englert, Heinrich C., 1997: HMR 1883, a novel cardioselective ATP-dependent potassium channel antagonist prevents ventricular fibrillation induced by myocardial ischemia

Rajagopalan Levasseur, P.; Vallee, E.; Bonnefoy, A.; Chantot, J. F.; Agouridas, C.; Bryskier, A.; Carbon, C., 1998: HMR 3647 Activity against Legionella pneumophila serogroup 1 in monocyte-derived macrophages and in experimental guinea pig infection models

Rajagopalan Levasseur, P.; Vallee, E.; Agouridas, C.; Chantot, J. F.; Bonnefoy, A.; Bryskier, A.; Carbon, C., 1997: HMR 3647 Activity against erythromycin-resistant pneumococci and Haemophilus influenzae in murine pneumonia models

Piper, K. E.; Rouse, M. S.; Patel, R.; Wilson, W. R.; Steckelberg, J. M., 1998: HMR 3647 treatment of beta-lactamase positive Haemophilus influenzae type b experimental pneumonia in immunocompetent mice

Graul, A.; Castaner, J., 1998: HMR-3647 Ketolide antibacterial

Edelstein, P. H.; Edelstein, M. A. C.; Ren, J., 1998: HMR3647 and HMR3004 in vitro and in vivo activity for Legionella spp

Nozaki, Yusuke; Matsunaga, Noriko; Ishizawa, Toshihiro; Ueda, Takuya; Takeuchi, Nono, 2008: HMRF1L is a human mitochondrial translation release factor involved in the decoding of the termination codons UAA and UAG

Schultheis, Holger; Thorwart, Anna; Lachnit, Harald, 2008: HMS A MATLAB simulator of the Harris model of associative learning

Ekataksin, W.; Wake, K.; Nishida, J.; Krasovich, M.; Mccuskey, R. S., 1993: HMS, hepatic microcirculatory subunit Three dimensional observations on development and spatial distribution in mammalian livers

Jimbow, Kowichi; Chen, Hua, 1994: HMSA-6 consists of two groups of structural proteins forming ER network and precursor vacuoles of secretory granules common to human neural crest cells

Yamazawa, Y.; Miyafuji, Y.; Zhong, X.L.; Kikuchi, Y.; Hemmi, H.; Ohtsuka, S.; Shimatake, H., 1998: HMSH2 codons 662 to 790 confers drug resistance to Escherichia coli

Rhyu, Mun Gan; Kang, Myoung Joo; Park, Won Sang; Jung, Yong Tae; Chung, Yuen Joon; Choi, Sang Wook, 1996: HMSH2 gene alterations are related to hypermutability in sporadic gastric carcinomas

Olschwang, S.; Laurent Puig, P.; Boisson, C.; Vogelstein, B.; Thomas, G., 1995: HMSH2 germline mutations screening in 50 familial cancer aggregations

Chadwick, R. B.; Conrad, M. P.; Kronick, M. N., 1995: HMSH2 mutation detection by direct automated fluorescent sequencing

Yamada, K.; Shimura, S.; Satoh, M.; Sasaki, T.; Yamauchi, K.; Takishima, T., 1994: HMT regulates histamine-induced Cl- secretion across the canine tracheal epithelium

Song, Y.; Silverman, M., 1998: HMUNC13- a novel human glucose regulatable gene A potential candidate for diabetic nephropathy

Patel, P.; Mendall, M. A.; Bond, A.; Khulusi, S.; Molineaux, N.; Levy, J.; Northfield, T. C., 1994: HMW H pylori antigens provide early assessment of eradication status

LiangTaiBo; YinYanPing; CaiRuiGuo; YanSuHui; LiWenYang; GengQingHui; WangPing; WuYunHai; LiYong; WangZhenLin, 2008: HMW-GS accumulation and GMP size distribution in grains of Shannong 12 grown in different soil conditions

ChengXueNi; ZhaoJiXin; QiaoSenTao; WuJun; LiuShuHui; YangQunHui; ChenXinHong; YangXiaoLing, 2008: HMW-GS components of some new wheat varieties in Guanzhong of Shaanxi Province

Corkin, S.; Amaral, D. G.; Johnson, K. A.; Hyman, B. T., 1994: HMs MRI scan shows sparing of the posterior half of the hippocampus and parahippocampal gyrus

Drummond, James; Li, Guo Min; Duckett, Derek; Longley, Matthew; Modrich, Paul, 1996: HMutL-alpha and hMutS-alpha function as heterodimers in human mismatch repair

Drummond, James; Li, Guo Min; Duckett, Derek; Modrich, Paul, 1996: HMutL-alpha and hMutS-alpha in human mismatch repair

Abramov, Mikhail; Schepers, Guy; Van-Aerschot, Arthur; Van-Hummelen, Paul; Herdewijn, Piet, 2008: HNA and ANA high-affinity arrays for detections of DNA and RNA single-base mismatches

Elena, C. D-De-La-Vega; Nogues, N.; Montoya, A. Fernandez; Oyonarte, S.; Solis, E.; Muniz-Diaz, E., 2008: HNA-1a, HNA-1b and HNA-1c gene frequencies in argentineans

Vos, P.; Mill, J. F.; Zhang, S.D.; Odenwald, W. F., 1993: HNF-3-beta, a potential A5 target, is expressed in midline structures of the embryonic murine CNS

Blakely, B. T.; Blau, H. M., 1994: HNF-4 mediated regulation of liver gene expression is defective in the BNLcl2 liver cell line

Niehof, Monika; Borlak, Juergen, 2008: HNF4 alpha and the Ca-Channel TRPC1 are novel disease candidate genes in diabetic nephropathy

Iwayanagi, Yuki; Takada, Tappei; Suzuki, Hiroshi, 2008: HNF4 alpha is a crucial modulator of the cholesterol-dependent regulation of NPC1L1

Kudrjavtseva, E. I.; Lazarevich, N. L.; Varga, E. V.; Morozova, O. V.; Cheremnova, O. A.; Ovchinnikov, D. A.; Shapiguzov, A. Y.; Turusov, V. S.; Engelhardt, N. V., 1998: HNF4-gene is involved in regulation of hepatocellular carcinoma differentiation status

Somasekhar, T.; Nordlander, R. H., 1993: HNK-1 and tenascin distribution in the developing neuromuscular system of Xenopus

Ogawa Goto, K.; Tanii, T.; Takahashi, E.; Kubota, K.; Abe, T., 1995: HNK-1 antigens and human cytomegalovirus infection

Qi, Y.; Streeten, B. W.; Wallace, R. N.; Hoepner, J. A., 1997: HNK-1 epitope on ocular and extraocular elastic system microfibrils and pseudoexfoliation aggregates

Qi, Y.; Wallace, R. N.; Hoepner, J. A.; Streeten, B. W., 1995: HNK-1 epitopes in normal and pseudoexfoliation lens capsules by tem

Ikeda, T.; Ohtani, H.; Shimokawa, I., 1994: HNK-1 expression pattern in bis-diamine induced malformed developing rat heart

Henebry, C.; Woods, C.; Schneider, J.; Katholi, R.; Woods, W., 1997: HNK-1 positive cells localized in embryonic cultured rat ventricular pacemaker

Norlander, R. H.; Booth, P. L., 1992: HNK1 and NCAM expression in cultures of developing Xenopus neural tissue

Baden, S. T.; Nordlander, R. H., 1993: HNK1 labeling of developing cranial nerves

Kunitomo, Kazufumi; Terashima, Yoshiyasu; Sasaki, Kenji; Komi, Nobuhiko; Yoshikawa, Reigetsu; Utsunomiya, Joji; Yasutomi, Masayuki, 1992: HNPCC in Japan

Fan, M.; Mu, Y. Y.; Guo, Q.; Liu, H.; Liu, S. H.; Gan, S. D., 1996: HNT-3 gene cloning and gene therapy of kainic acid-induced lesions in rat hippocampus

Haber, Jim; Sugawara, Neal; Fishman Lobell, Jacqueline; White, Charles; Ray, Bryan; Ivanov, Evgenyi, 1993: HO endonuclease and other exo- and endo-nucleases involved in site-specific homologous recombination in Saccharomyces cerevisiae

Fasullo, Michael T., 1993: HO endonuclease generated double-strand DNA breaks can induce damage-inducible genes Saccharomyces cerevisiae

Turner, Christopher; Sharp, Frank R.; Panter, S. Scott, 1996: HO-1 activation in brain following subarachnoid injections of hemoglobin, heme and heme analogs

Paschen, W.; Schmitt, J.; Uto, A.; Djuricic, B., 1995: HO-1 expression after reversible cerebral ischemia

Converso, Daniela, P.; Taille, Camille; Carreras, Maria-Cecilia; Jaitovich, Ariel; Poderoso, Juan-Jose; Boczkowski, Jorge, 2000: HO-1 is located in liver mitochondria and modulates mitochondrial heme content and metabolism

Dennery, P. A.; Lee, C. S.; Poss, K. D., 1997: HO-2 knock-out mice have increased lung oxidative injury in hyperoxia

Kirkland, Kenneth J., 1995: HOE 075032 for wild mustard control in Canola

Chen, Xiu; Liu, Li Ying; Jin, Zu Qiu; Li, Nian Seng; Cai, Chao Min, 1996: HOE694 protects isolated heart and aortic endothelium of rabbits against free radical-induced injury

Sugimura, H.; Kohno, T.; Nagura, K.; Wakai, K.; Genka, K.; Igarashi, H.; Shinmura, K.; Yokota, J., 1998: HOGG1 polymorphism and lung cancer susceptibility

Snow, Peter; Buss, Leo W., 1994: HOM/Hox-type homeoboxes from Stylaria lacustris

Feneley, M. R.; Sowter, C.; Kirby, R. S.; Slavin, G., 1995: HOME measurement of epithelial volume improves the ability of serum PSA to distinguish residual malignancy in patients with incidental carcinoma of the prostate

Gray, E.; Carey, F. A.; Dye, R., 1994: HOME ploidy, a comparison with other cytometry methods

Duvall, E.; Gray, E., 1994: HOME, a new system for training and audit in morphometry

Beine,H.; Colussi,A.J.; Amoroso,A.; Esposito,G.; Montagnoli,M.; Hoffmann,M.R., 2008: HONO emissions from snow surfaces

Pieroni, Stefania; Della-Fazia, Maria-Agnese; Castelli, Marilena; Piobbico, Danilo; Bartoli, Daniela; Brunacci, Cinzia; Bellet, Marina-Maria; Viola-Magni, Mariapia; Servillo, Giuseppe, 2008: HOPS is an essential constituent of centrosome assembly

Slungaard, A.; Hockett, M.; Decker, T.; Kovacs, A.; Bach, R. R.; Key, N. S., 1995: HOSCN, the major physiologic product of eosinophil peroxidase catalysis, induces endothelial cell tissue factor expression and activates NF-kappa-B

Franc, Francis H. Roger; Alban, Anita; Barber, Barry; Beguin, Claire; Bruster, Steve; Closon, Marie Christine; Ruiz, Ulises; Taroni, Francesco; Uberla, Karl; Van Den Heuvel, Richard, 1992: HOSCOM results A European health data base for hospital comparisons and management

Larochelle, P.; Carruthers, G.; Vint Reed, C., 1997: HOT study Canadian experience after 24 months

Perkins, A. C.; Adams, J. M.; Walter, S. Cory; Hall, Eliza, 1993: HOX 24 and a milieu of high IL-3 concentration deliver synergistic self-renewal signals

Petersen, D.; Fuller, J.; Izadi, P.; Pattengale, P. K.; Sakaquchi, M.; Malik, P.; Kohn, D. B.; Gasson, J. C.; Crooks, G. M., 1997: HOX A5 expression in human hematopoietic progenitor cells directs differentiation toward myeloid at the expense of erythroid differentiation

Torok, M. A.; Gardiner, D. M.; Bryant, S. V., 1994: HOX D expression in developing and regenerating axolotl limbs

Dimartino, J. F.; Selleri, L.; Firpo, M.; Smith, K.; Rhee, J.; Van Deursen, J.; Grosveld, G.; Cleary, M. L., 1998: HOX cofactors PBX1 and PBX2 are required for normal hematopoiesis

Flagiello, D.; Malfoy, B.; Molinari Tosatti, M. P.; Dutrillaux, B.; Poupon, M. F.; Cillo, C., 1995: HOX gene expression and DNA methylation in human small cell lung cancers

Cillo, C.; Barba, P.; Tiberio, C.; Magli, M. C., 1993: HOX gene expression in human cancer

Alonso Varona, Ana; Castro, Begona; Calle, Yolanda; Palomares, Teodoro; Bilbao, Pedro; Flagiello, Domenico; Poupon, Marie France; Malfoy, Bernard, 1996: HOX genes and cell adhesion molecules in cancers

Cillo, Clemente, 1995: HOX genes in human cancer

Cillo, Clemente, 1995: HOX genes in human cancers

Jacobs, David K.; Dawson, Mike N.; Lee, Shannon E., 1998: HOX, NK2, and paired-like less than gene trees in metazoan evolution

Oefelein, Michael; Chin Chance, Catherine; Bushman, Wade, 1994: HOX-48 gene expression within the developing mammalian prostate

Largman, C.; Lawrence, H. J.; Humphries, R. K.; Sauvageau, G., 1998: HOX-induced enhancement of in vivo and in vitro proliferative capacity and gene therapeutic methods

Roberts, Charles W. M.; Hatano, Masahiko; Kawabe, Takumi; Korsmeyer, Stanley J., 1993: HOX11, a homeobox gene deregulated by the t of human T cell all is normally expressed in the hindbrain of the developing embryo

Hough, Margaret R.; Reis, Marciano D.; Dube, Ian D., 1998: HOX11, a homeodomain-containing transcription factor dysregulated in the T translocation of T-ALL induces B-lymphoid malignancies in transgenic mice

Dube, Ian D.; Hough, Margaret R.; Reis, Marciano D., 1998: HOX11, a homeodomain-containing transcription factor dysregulated in the T translocation of lymphoid malignancy, induces B-lymphoid malignancies in IgHmu-HOX11 transgenic mice

Higgins, L. M.; Shields, J. G.; Macdonald, T. T., 1997: HOX40-hIgG fusion protein prevents colitis in mice

Fleischman, R.; Letestu, R.; Mi, X.; Stevens, D.; Winters, J.; Debili, N.; Vainchenker, W., 1998: HOXA-10 is the predominant HOX gene expressed in human megakaryocytic cells but is normal in the thrombocytopenia with absent radius syndrome

Sugimoto, Yuya; Nakamura, Satoki; Okinaka, Keiji; Hirano, Isao; Ono, Takaaki; Shigeno, Kazuyuki; Shinjo, Kaori; Ohnishi, Kazunori, 2008: HOXA10 expression induced by Abl kinase inhibitors enhanced apoptosis through PI3K pathway in CML cells

Fiegl, Heidi; Windbichler, Gudrun; Mueller-Holzner, Elisabeth; Goebel, Georg; Lechner, Matthias; Jacobs, Ian, J.; Widschwendter, Martin, 2008: HOXA11 DNA methylation - A novel prognostic biomarker in ovarian cancer

Shaut, Carley, A. E.; Keene, Douglas, R.; Sorensen, Lise, K.; Li, Dean, Y.; Stadler, H. Scott, 2008: HOXA13 is essential for placental vascular patterning and labyrinth endothelial specification

Shen, W.F.; Rosenfeld, S.; Kwong, A.; Komuves, L.; Lawrence, H. J.; Largman, C., 1998: HOXA9 forms triple complexes with PBX and MEIS1 in myeloid cells

Larochelle, Andre; Dunbar, Cynthia, E., 2008: HOXB4 and retroviral vectors adding fuel to the fire

Care, A.; Valtieri, M.; Mattia, G.; Meccia, E.; Masella, B.; Luchetti, L.; Colombo, M. P.; Peschle, C., 1996: HOXB7 overexpression in linked to stem cell proliferation and granulopoietic-restructed progenitor cell differentiation

Basu, Amaresh; Fagan, Patrick; Garcia, Arnold; Frazer, John; Lapinski, Janice; Tuttle, Ronald; Loullis, Costas, 1995: HP 228 decreases plasma levels of endotoxin induced IL-1-beta, IL-6 and TNF-alpha in mice

Corcos, I.; Thompson, E. E.; Omholt, P.; Lee, M. D.; Mcpherson, S.; Mcdowell, R.; Houghten, R.; Girten, B., 1997: HP 228 is a potent agonist of melanocortin receptor 4, and significantly attenuates obesity and diabetes in Zucker fatty rats

Fagan, P.; Lapinski, J.; Garcia, A.; Samson, G.; Loullis, C.; Basu, A., 1996: HP 228 modulates endotoxin induced TNF-alpha and IL-1-beta levels in mouse organ tissues

Omholt, P.; Mcpherson, S.; Mcdowell, R.; Girten, B., 1998: HP 228 reduces chronic indomethacin induced gastropathy and associated mortality

Pospai, D.; Vissuzaine, C.; Vallot, T.; Merrouche, M.; Mignon, M., 1997: HP colonizes gastric metaplasia resulting in duodenitis and ulceration Isnt too good to be true?

Corvaglia, L.; Bontems, P.; Keppens, E.; Vandenborre, C.; De Prez, C.; Cadranel, S., 1997: HP infection in children Comparison of results with serology and 13C-urea breath test

Catalano, F.; Terranova, R.; Brogna, A.; Branciforte, G.; Catanzaro, R.; Liberti, A.; Bentivegna, C.; Luca, S., 1995: HP positive functional dyspepsia in elderly patients Comparison of treatments

De Reuck, M.; Brad, M.; Otero, J.; Cozzoli, A.; Denis, P.; De Koster, E.; Deltenre, M., 1996: HP prevalence in IBD patients Role of IBD treatment

De Koster, E.; Cozzoli, A.; Vandenborre, C.; Jonas, C.; Denis, P.; Otero, J.; Deltenre, M., 1997: HP resistance to macrolides increases, to imidazoles remains stable

Fujiwara, Y.; Wyle, F.; Arakawa, T.; Kobayashi, K.; Tarnawski, A., 1995: HP toxin reduces EGF binding to its receptor and proliferative response of human gastric Kato III cells to EGF stimulation Important mechanism for HP interference with the ulcer healing?

Jonas, C.; De Koster, E.; Nyst, J. F.; Van Gossum, M.; Depierreux, M.; Deltenre, M., 1993: HP treatment The macrolide trail revisited

Walter, H.; Veerraju, P.; Dharanipriya, B.; Khaja, M. N.; Harms, Margret, 1994: HP, TF and GC phenotype and allele frequencies in four South Indian population groups

French, C. K.; Yamamoto, K. K.; Chow, P. M.; Alido, N. T., 1998: HP-8 autoantigen

Madisch, A.; Grabowski, G.; Schneider, A.; Malfertheiner, P.; Schneider, B.; Plein, K.; Hotz, J., 1998: HP-positive versus HP-negative dyspepsia Are there differences in sociodemographic determinants and symptom pattern

Ayoub, Nabieh; Jeyasekharan, Anand, D.; Bernal, Juan, A.; Venkitaraman, Ashok, R., 2008: HP1-beta mobilization promotes chromatin changes that initiate the DNA damage response

Ando, T.; Israel, D. A.; Kusugami, K.; Blaser, M. J., 1998: HP333, a dprA homolog, is required for DNA transformation of Helicobacter pylori

Tornatore, Kathleen M.; Reed, Kristine A.; Venuto, Rocco C., 1996: HPA aix response to chronic glucocorticoid therapy in renal transplant recipients

Chicz De Met, A.; Simon, B.; Wu, T. D.; Cunanan, H. C.; Cornett, H. A.; Lee, D.; Johnson, A. F.; Thai, T. D.; Scott, M. S.; Fisher, T., 1995: HPA axis and anxiety in adolescent pregnancy

Chicz Demet, A.; Simon, B.; Wiger, J.; Kim, T.; Demet, E. M., 1993: HPA axis and depression in adolescent pregnancy

Thakore, Jogin H., 1996: HPA axis overactivity and the pathogenesis of depression

Gotlib, Ian, H.; Joormann, Jutta; Minor, Kelly, L.; Hallmayer, Joachim, 2008: HPA axis reactivity A mechanism underlying the associations among 5-HTTLPR, stress, and depression

Nelson, H.; Kane, R. E.; Bagchi, P.; Banerji, D.; Staudinger, H., 1998: HPA function in asthmatic adults after 12 months of treatment with Azmacort HFA-134A, 75 mcg or Azmacort HFA-134A, 225 mcg oral inhalers

Metcalfe, P.; Cavanagh, G.; Ouwehand, W. H., 1998: HPA genotyping by PCR-SSP Report of 3 workshops

Quirin, Markus; Pruessner, Jens, C.; Kuhl, Julius, 2008: HPA system regulation and adult attachment anxiety Individual differences in reactive and awakening cortisol

Peyruchaud, O.; Bourre, F.; Morel Kopp, M.C.; Reviron, D.; Mercier, P.; Nurden, A.; Kaplan, C., 1996: HPA-10w-b Genetic determination of a new platelet specific alloantigen on glycoprotein IIIa and its expression in Cos-7 cells

Castro, V.; Annichino Bizzacchi, J. M.; Costa, F. F.; Arruda, V. R., 1996: HPA-1b of platelet glycoprotein IIIa as a risk factor for arterial disease

Sondeijker, Frouke, E. P. L.; Ferdinand, Robert, F.; Oldehinkel, Albertine, J.; Tiemeier, Henning; Ormel, Johan; Verhulst, Frank, C., 2008: HPA-axis activity as a predictor of future disruptive behaviors in young adolescents

Coryell, William; Fiedorowicz, Jess; Zimmerman, Mark; Young, Elizabeth, 2008: HPA-axis hyperactivity and mortality in psychotic depressive disorder Preliminary findings

Weitzhandler, M.; Thayer, J.; Rohrer, J.; Avalovic, N., 1996: HPAE-PAD analysis of terminal N-acetylglucosamine using the CarboPac MA1 column

Weitzhandler, Michael; Avdalovic, Nebojsa, 1997: HPAE-PAD monosaccharide and oligosaccharide analysis of glycoproteins electrotransferred onto polyvinylidene fluoride membranes

Weitzhandler, Michael; Rohrer, Jeffrey; Thayer, James R.; Avdalovic, Nebojsa, 1998: HPAEC-PAD analysis of monosaccharides released by exoglycosidase digestion using the CarboPac MA1 column

Le Hegarat, F.; Arnold Schulz Gahmen, B.; Hirschbein, L., 1994: HPB12, a B subtilis bifunctional nucleoid protein in involved in ribosome assembly and DNA compaction

Baas, D.; Hofstein, R.; Ghandour, M. S.; Barnstable, C. J., 1996: HPC-7, a novel stage specific oligodendrocyte marker

Stevenson, Robert, 1993: HPCE 93 More new applications

Thomas, Chadwick V.; Cater, Amy C.; Wheeler, John J., 1993: HPCE as an analytical probe for assessing irreversible ligand/macromolecule binding interactions

Siluveru, Madhusudhan; Stewart, James T., 1997: HPCE determination of R and S mepivacaine in human serum using a derivatized cyclodextrin and ultraviolet detection

Hasbun,R.; Valledor,L.; Rodriguez,J.L.; Santamaria,E.; Rios,D.; Sanchez,M.; Canal,M.J.; Rodriguez,R., 2008: HPCE quantification of 5-methyl-2-deoxycytidine in genomic DNA methodological optimization for chestnut and other woody species

Fisher, D. A., 1997: HPDE IV-C A human phosphodiesterase IV isozyme

Fisher, D. A., 1997: HPDE IV-C A novel human phosphodiesterase IV isozyme

Sondergaard, Helle-Bach; Brodin, Birger; Nielsen, Carsten-Uhd, 2008: HPEPT1 is responsible for uptake and transport of Gly-Sar in the human bronchial airway epithelial cell-line Calu-3

Hunter, Duncan H.; Mueller, Kevin; Won, Gina Wong, 1995: HPIC analysis of radioiodides Direct determination of isotopic and chemical purity

Stevenson, Robert, 1993: HPLC 93 Focus on biotechnology

Tassin, J. P.; Dubois, J.; Hanocq, M.; Atassi, G., 1995: HPLC Determination Of A New Multidrug Resistance Modulator Extracted From Cancer Cells in vitro

Jiao, Shou Zong, 1993: HPLC Determination of isosorbide dinitrate and its tablets

Kusters, Ernst; Dosenbach, Cornelia, 1995: HPLC Separation of the Enantiomers of Racemic Benzergoline Derivatives on a Chiral Binaphthalene Covalently Bonded to Silica Gel

Parsons, L. C.; Dupakova, M.; Miketova, P.; Hamilton, A., 1998: HPLC analysis CSF Intracerebral hemorrhage

Li, Juan; Wang, Zhi-Wei; Zhang, Lei; Liu, Xiao; Chen, Xiao-Hui; Bi, Kai-Shun, 2008: HPLC analysis and pharmacokinetic study of quercitrin and isoquercitrin in rat plasma after administration of Hypericum Japonicum thunb extract

Neacsu,M.; Vicas,S.; Socaciu,C., 2008: HPLC analysis coupled with diode array detector used in determination of isoflavone aglycones from different Romanian varieties of soybeans

Wise, Carolyn K.; Hass, Bruce S., 1994: HPLC analysis for 5-methyldeoxycytidine in cellular DNA obtained directly from the culture flask

Shi, R.; Jung, P.; Benet, L. Z.; Gee, W. L.; Weigl, P.; Bansal, S.; Yacobi, A., 1992: HPLC analysis for deethylpiperacillin in plasma and bile

Shi, Robert J.Y.; Nguyen, Hahn; Hann, Milagros; Gee, Winnie L.; Lin, Emil T., 1994: HPLC analysis for metaproterenol in plasma using a silica gel column and an aqueous mobile phase

Shi, R.; Liu, S.; Gee, W. L.; Benet, L. Z.; Lin, E. T.; Goodman, A., 1992: HPLC analysis for metformin in blood, plasma and urine using a silica gel column and an aqueous mobile phase

Tse, Mary; Wu, Julie; Gee, Winnie; Liu, Jeremy; Lin, Emil, 1995: HPLC analysis in acyclovir in human plasma

Skerjanec, A.; Tam, Y. K., 1993: HPLC analysis of RO 40-5967 in human and dog plasma

Zheng, Ming; Mcerlane, Keith M.; Kitts, David D., 1993: HPLC analysis of Romet-30 in chinook salmon Wash-out times, tissue distribution in muscle and liver, and metabolism of sulfadimethoxine

Johnston, T. V.; Morris, J. R., 1997: HPLC analysis of Vitis vinifera cv Cabernet Sauvignon and Vitis rotundifolia cv Noble wine pigment liquid chromatographic fractions

Chen, H.M.; Scott, B. K.; Braun, K. P.; Peterson, C. M., 1995: HPLC analysis of acetaldehyde in hemoglobin fractions separated by cation exchange chromatography Three new peaks associated with acetaldehyde

Nunez, A.; Piazza, G. J., 1994: HPLC analysis of acylglycerols and phospholipids with a C18-hema polymer column

Rahn, Peter C.; Bickler, J. Robert, 1996: HPLC analysis of basic compounds with mobile phases above pH 7

Handelman, Garry J.; Huang, Shu Wen Sheena; Fenz, Reiner; Frankel, Edwin N.; German, J. Bruce, 1993: HPLC analysis of cholesterol ester oxidation products to evaluate the early phase of LDL oxidation

O'connor, E. F.Jr.; Ostheimer, D.; Wu, A., 1994: HPLC analysis of cocaine and benzoylecgonine in urine, plasma and meconium using solid phase extraction and diode array detection

Liu, Y.; Shan, L.; Mcconnell, J. P.; Anderson, D. J.; Shainoff, J. R., 1998: HPLC analysis of fibrinogen and fibrinogen degradation products

LuoMina; MaHuaQiao; LiuXia; JiangShengXiang, 2008: HPLC analysis of flavonoids in Lamiophlomis rotata

Tang Shu, Xu Bingkun, 1996: HPLC analysis of hesperidin in Xiangshaliujun concentrate pill

Di Pietra, A. M.; Cavrini, V.; Andrisano, V.; Gatti, R., 1993: HPLC analysis of imidazole antimycotic drugs in pharmaceutical formulations

Pinkwart, W.; Diettrich, B.; Luckner, M., 1992: HPLC analysis of in vivo and in vitro cultivated crown gall tumor cells of Digitalis lanata

Nagaura, H.; Tamaki, T.; Kozaki, M.; Hirano, T.; Oka, K., 1993: HPLC analysis of lymphocyte blastogenesis promoting factors in haemo-dialysate of patients with chronic renal failure

Dong,H.R.; Liu,X.Q., 2008: HPLC analysis of magnolol and honokiol in Magnoliae Cortex after solvent sublation

Geodakyan, S. V.; Voskoboinikova, I. V.; Kolesnik, Yu A.; Tyukavkina, N. A.; Kolkhir, V. K.; Zyuzin, V. A., 1993: HPLC analysis of mangiferin in the blood and urine of rats

El Gizawy, Samia M., 1993: HPLC analysis of metronidazole and diloxanide furoate in its dosage forms

Sahartova, O.; Shatz, V.; Kalvins, I., 1993: HPLC analysis of mildronate and its analogues in plasma

Talbott, T.; Singer, S., 1996: HPLC analysis of molluscicidal toxins from four different Bacillus species

Mahmud, Iftekher; Krishnan, Padmanaban G.; Mathees, Duane P., 1996: HPLC analysis of niacin by postcolumn derivatization

Anyakora,C.; Afolami,I.; Ehianeta,T.; Onwumere,F., 2008: HPLC analysis of nicotinamide, pyridoxine,riboflavin and thiamin in some selected food products in Nigeria

Peelen, Gijsbert O. H.; De Jong, Jan G. N.; Wevers, Ron A., 1994: HPLC analysis of oligosaccharides in urine from oligosaccharidosis patients

Tse, Mary M.; Liu, Chu Min; Wu, Julie; Gee, Winnie L.; Lin, Emil T., 1996: HPLC analysis of omeprazole in human plasma

Veit, M.; Van Rensen, I.; Kirch, J.; Geiger, H.; Czygan, F.C., 1992: HPLC analysis of phenolics and flavonoids in Arctostaphylos uva ursi

Zhang, Hailang; Stewart, James T.; Ujhelyi, M., 1994: HPLC analysis of pindolol enantiomers in human serum using a reversed phase chiral column and solid phase extraction

Usha, K.; Goswami, A. M.; Sharma, H. C.; Singh, Bhupinder, 1997: HPLC analysis of plant phenols in mango and their role on malformation

Ye, Ming Y.; Shen, Ying; West, Candid, 1998: HPLC analysis of polyamines as their benzoylated derivatives in cultured HELA cells

Baldi, A.; Romani, A.; Tatti, S.; Mulinacci, N.; Vincieri, F. F., 1995: HPLC analysis of polyphenolic compounds present in Olea europea L

Romani, A.; Baldi, A.; Vincieri, F. F., 1995: HPLC analysis of polyphenolic compounds present in the grapes of Vitis vinifera L

Picinelli, A.; Suarez, B.; Moreno, J.; Dapena, E.; Mangas, J., 1995: HPLC analysis of polyphenols in apple tree leaves

Piga,A.; Caro,A.del; Milella,G.; Pinna,I.; Vacca,V.; Schirru,S., 2008: HPLC analysis of polyphenols in peel and pulp of fresh figs

Xia, Chunsheng; Dang, Yuhong; Brown, Olen R., 1998: HPLC analysis of quinolinic acid, a NAD biosynthesis intermediate, after fluorescence derivatization in an aqueous matrix

Toiu,A.; Vlase,L.; Oniga,I.; Tamas,M., 2008: HPLC analysis of salicylic acid derivatives from Viola species

Wei, Alan T.; Dimenna, Gary P.; Karnes, H. Thomas, 1992: HPLC analysis of sodium salinomycin in human plasma using derivatization and heart cut, column switching

Mokry, M.; Klimes, J.; Zahradnicek, M., 1994: HPLC analysis of some sulfonamides in selected pharmaceutical formulations

Lucero, M.; Farrington, H.; Gilly, W., 1993: HPLC analysis of squid ink reveals olfactory stimuli, L-dopa and dopamine

Shofran, B. G.; Mcfeeters, R. F.; Fleming, H. P., 1997: HPLC analysis of sulfur compounds in cruciferous vegetables using pulsed electrochemical detection

Bryan, Peter D.; Stewart, J. T.; Capomacchia, A. C., 1992: HPLC analysis of tetracyclines and their degradation products in dosage forms

Meng, Q. C.; Kramer, T. H.; Arthur, G. R.; Kim, P.; Ferrante, F. M., 1998: HPLC analysis of the 2-chloroprocaine metabolite diethylaminoethanol in blood using HPLC

Mercolini, Laura; Colliva, Carolina; Amore, Mario; Fanali, Salvatore; Raggi, Maria-Augusta, 2008: HPLC analysis of the antidepressant trazodone and its main metabolite m-CPP in human plasma

Masciangioli, Tina M.; Wallace, James W.; Bacon, J. Roger, 1994: HPLC analysis of the flavonoid constituents of black walnut

Rehwald, A.; Meier, B.; Mutsch, M.; Sticher, O., 1993: HPLC analysis of the flavonoids of Crataegi folium cum flore

Johnson, S. W.; Yeung, A. T.; Brennan, J.; Handel, L. M.; Godwin, A. K.; Hamilton, T. C., 1993: HPLC analysis of the formation and removal of platinum-DNA adducts from cisplatin-sensitive and resistant ovarian cancer cell lines

Beck, D. E.; Jordan, B. G.; O'donovan, G. A., 1996: HPLC analysis of the pyrimidine salvage enzymes, uridine hydrolase and uridine phosphorylase in enterics

She-Gai-Mei; Zhang-Xiang-Lan; Chen-Ke-Ke; Xu-Mei; Zhang-Ying-Jun; Yang-Chong-Ren, 2008: HPLC analysis of theanine and gallic acid in the species of Camellia sect Thea

Jordan, B. G.; Beck, D. E., 1997: HPLC analysis of uridine hydrolase in KP1130, a Salmonella typhimurium mutant lacking uridine phosphorylase

Brandsteterova, Eva; Krajnak, K.; Skacani, I., 1995: HPLC analysis of urinary catecholamines using affinity SPE procedure

Aslam,J.; Mohajir,M.S.; Khan,S.A.; Khan,A.Q., 2008: HPLC analysis of water-soluble vitamins in in vitro and ex vitro germinated chickpea

ChiYuJie; YanHongBo, 2008: HPLC analysis on different phenolic acids and their contents of david poplar wood degraded by 6 species of wood white-rot fungi

Clejan, Sanda, 1998: HPLC analytical methods for the separation of molecular species of fatty acids in diacylglycerol and cellular phospholipids

Thompson, D. Charles; Wyrick, Steven D.; Holbrook, David J.; Chaney, Stephen G., 1995: HPLC and 31P NMR characterization of the reaction between antitumor platinum agents and the phosphorothioate chemoprotective agent S-2- ethylphosphorothioic acid

Saugy, M.; Tritten, J. J.; Rivier, L., 1993: HPLC and GC-MS determinations of two anti-viral substances in ocular fluids after transscleral application

Davies, Michael J.; Hounsell, Elizabeth F., 1998: HPLC and HPAEC of oligosaccharides and glycopeptides

Lacroix, Pauline M.; Dawson, Brian A.; Sears, Roger W.; Black, D. Bruce, 1994: HPLC and NMR methods for the quantitation of the -enantiomer in - -timolol maleate drug raw materials

Moller, L.; Zeisig, M., 1994: HPLC and TLC analyses of 32P-postlabelled DNA adducts-recent developments

Pittenauer, Ernst; Caparros Rodriguez, Marta; Depedro, Miguel A.; Allmaier, Guenter; Schmid, Erich R., 1993: HPLC and californium-252 plasma desorption-mass spectrometry of muropeptides isolated from Escherichia coli

Hadad, Ghada, A.; El-Gindy, Alaa; Mahmoud, Waleed, M. M., 2008: HPLC and chemometrics-assisted UV-spectroscopy methods for the simultaneous determination of ambroxol and doxycycline in capsule

Reepmeyer, John C.; Nasr, Mohen M., 1997: HPLC assay and impurity profile of thiostrepton

Ko, Chan Y.; Micheel, Arthur P., 1994: HPLC assay and purity of topiramate drug substance

Vesper, H. W.; Myers, G., 1998: HPLC assay as reference base for the determination of pyridinoline and deoxypyridinoline in urine and serum

Bullen, W.; Suri, A.; Lathia, C., 1994: HPLC assay for CI-1010, an alkylating radiosensitizer, in rat plasma

Bullen, W.; Brodfuehrer, J.; Walter, G.; Wong, B.; Johnson, E.; Whitfield, L., 1992: HPLC assay for CI-980, a novel mitotic inhibitor, in human plasma and urine

Rivera, Paul; Brodfuehrer, Joanne; Brucki, Lawrence; Guttendorf, Robert, 1998: HPLC assay for benzoisothiazole antiviral agent, Cl-1012, following reduction of Cl-1012 and mixed disulfides in plasma to PD 162401 equivalents

Beyerlein, David; O'rourke, R.; Steele, J., 1995: HPLC assay for determination of aptiganel in human plasma

Horton, M.; Steele, J.; O'rourke, R., 1994: HPLC assay for determination of famotidine in human plasma

Le Guellec, C.; Lacarelle, B.; Giocanti, M.; Durand, A., 1994: HPLC assay for dextromethorphan Application to the determination of cytochrome P4502D6 oxidation phenotype

Salyani, S.; Dawson, R.Jr; Defiebre, N. C.; Martin, M. W.; De Fiebre, C. M., 1998: HPLC assay for nictotine and cotinine in plasma and brain

Kuo, A. K.; Still, R.; Cale, S.; Mcdowell, I. F. W., 1996: HPLC assay for plasma homocysteine utilising cysteamine as internal standard

Moser, A.; Scholz, J.; Siebecker, F., 1995: HPLC assay for quantitating salsolinol in the urine of patients with Parkinsons disease

Noguez, Angelica; Fuentes, Ines; Jung, Helgi, 1992: HPLC assay for the analysis of oxcarbazepine and its main metabolites in plasma or serum

Hegeman, Tim; Johnson, Richard, 1996: HPLC assay for the determination of caffeine metabolites in human urine

Kishore, Vimal; Womack, Iolanda M.; Lee, Arthur S.; Kamath, Burde; Agrawal, K. C., 1996: HPLC assay for the simultaneous analysis of prostacyclin analog iloprost and prostaglandin E analog misoprostol

Jang, Eun Ju; Lee, Young Joo; Park, Man Gi; Shim, Chang Koo, 1995: HPLC assay of 6-methoxy-2-naphthylacetic acid, a major metabolite of nabumetone, in human serum

Tollefson, J.; Brisson, J.; Addison, T.; Hosoe, K., 1995: HPLC assay of KRM-1648 in rat and dog whole blood

Phadungpojna, S.; Andersson, B.; Williams, T.; Chow, D. S.L., 1995: HPLC assay of busulfan for organ distribution evaluation in rats

White, L. O.; Reeves, D. S.; Lovering, A. M.; Macgowan, A. P., 1993: HPLC assay of cefixime in serum and CSF

El Dawy, M. A.; Habeeb, A. A.; Mabrouk, M. M.; El Bastawissy, Iman A., 1994: HPLC assay of lidocaine hydrochloride and prednisolone acetate in anti-haemorrhoidal preparations

El Dawy, M. A.; Habeeb, A. A.; Mabrouk, M. M.; El Bastawissy, Iman A., 1994: HPLC assay of reproterol hydrochloride

Yeung, Pollen; Ding, Lixia; Casley, William, L., 2008: HPLC assay with UV detection for determination of RBC purine nucleotide concentrations and application for biomarker study in vivo

Haase, F. C., 1995: HPLC avidin monomer affinity resin

Dumaresq, H.; Cheung, E.; Abdul Wajid, A., 1997: HPLC based perfusion immunoassay for anti-MUC1 antibody using non covalent adsorption of MUC1 antigen on AD immunosensor cartridge

Thompson, D. C.; Holbrook, D. J.; Chaney, S. G., 1994: HPLC characterization of organ-specific biotransformation of ormaplatin in tumor-bearing rats protected with WR-2721

Wainer, Irving W., 1993: HPLC chiral stationary phases for the stereochemical resolution of enantiomeric compounds The current state of the art

Kokate, Amit; Li, Xiaoling; Jasti, Bhaskara, 2008: HPLC detection of marker compounds during buccal permeation enhancement studies

Epemolu, R. O.; Ackerman, R.; Porter, J. B.; Hider, R. C.; Damani, L. A.; Singh, S., 1994: HPLC determination of 1,2-diethyl-3-hydroxypyridin-4-one , its iron complex -3 and glucuronide conjugate

Yang, Gang; Wu, Xin Wei; Feng, Guo Kang; Lin, Hong; Chen, Wei Dong; Li, Xiu Rong; Huang, Hong Xia, 1993: HPLC determination of 18 amino acids with internal standard

Jia, Z. P.; Xu, L. T.; Wang, D. M.; Xie, J. W., 1995: HPLC determination of 4- amino-4-demethylepipodophyllotoxin in rat plasma and studies of its pharmacokinetics

Dai, Qi Chang, 1998: HPLC determination of 4-chloroacetanilide in paracetamol

Li, Weiyong; Deng, Jungang; Qiao, Jian; Li, Qian; Zhang, Ying, 2008: HPLC determination of 4-hydroxy-anethole trithione in plasma via enzymatic hydrolysis and its application to bioequivalence study

Weng, N. D.; Johnson, T. C.; Carlson, A.; Hulse, J. D.; Lee, J. W.; Rogers, S.; Lynn, M., 1994: HPLC determination of E5531, a lipid A antagonist, in an ascending dose safety and tolerance study

Kinzler, Jacquelyn A.; Almirez, Ramona G.; Conner, Dale P., 1994: HPLC determination of NPC 17731 in plasma after pre-column derivatization

King, D. T.; Venkateshwaran, T. G.; Stewart, J. T., 1993: HPLC determination of a doxorubicin, ondansetron and vincristine mixture

Zhang, Hailang; Stewart, James T., 1996: HPLC determination of a etoposide and idarubicin mixture in 09 percent sodium chloride injection

Cheng, Y.F.; Bean, L.; Iraneta, P.; Neue, U., 1997: HPLC determination of antidepressants and their metabolites in plasma

Simmons, Bradley R.; Stewart, James T., 1995: HPLC determination of atenolol in human serum on underivatized silica using solid phase extraction

De Orsi, D.; Gagliardi, L.; Chimenti, F.; Tonelli, D., 1995: HPLC determination of beclomethasone dipropionate and its degradation products in bulk drug and pharmaceutical formulations

Helmsing, Pieter J.; Huisman, Ruud; Van Der Weele, Annemaire, 1993: HPLC determination of caffeine and theophylline by direct serum injection

Ferland, G.; Gevry, G.; Seidou, B.; Delisle, H., 1996: HPLC determination of carotenoids in wild green leaves of Niger

Kamani, G.; Low, C. L.; Valerie, T. T. H.; Chui, W. K., 1998: HPLC determination of cefazolin in plasma, urine and dialysis fluid

Malan, Corneli E. P.; De Villiers, M. M.; Handford, Julia S.; Swanepoel, Erna, 1996: HPLC determination of closantel in multi-component anthelmintic suspensions and tablets

Zhu, Yao Hua; Chen, Gui Liang; Zhao, Wei Jun; Zhang, Shun Mei, 1994: HPLC determination of cyclophosphamide

Dietrich, P. G.; Buechele, B.; Molnar, I., 1992: HPLC determination of cytarabine

Staab, A.; Scheithauser, S.; Mutschler, E.; Blume, H., 1994: HPLC determination of denaverine and propiverine in human plasma

Zhong, D.; Blume, H. , 1994: HPLC determination of diprafenon and its active metabolite 5-hydroxydiprafenon in human plasma

Delong, Allyn F.; Oldham, Samuel W.; NyhartEldon H.Jr.; Hyslop, David L., 1993: HPLC determination of duloxetine and metabolite in humans

Hellstrom,J.K.; Mattila,P.H., 2008: HPLC determination of extractable and unextractable proanthocyanidins in plant materials

Jiao Guo Hua, Li Bao You; Zhang Qi Chang, 1996: HPLC determination of fleroxacin tablets

ELaiMing; WangWei; SongGe; XiaXingHao; YuLiTao, 2008: HPLC determination of furosine in dairy products

Khalil, Saleh A. H.; Abu Baker, M. A. Y.; Al Shareef, A. H., 1998: HPLC determination of glibenclamide and its two impurities

Ge Shu Lan, Yu Li; Shan Hong Bin, 1995: HPLC determination of irsogladine and its tablets

Seifart, H. I.; Gent, W. L.; Parkin, D. P.; Donald, P. R., 1994: HPLC determination of isoniazid, acetylisoniazid and hydrazine concentrations in plasma samples from TB patients

Xu, Jianling; Lee, Hsin Jaw; Cradock, James, 1996: HPLC determination of ketamine hydrochloride and benzethonium chloride in ketamine hydrochloride injection

Chen Rui Zhu, Ge Qing Hua; Shi Li Xi, 1997: HPLC determination of lidamidine hydrochloride

Gumbhir, Kavita; Mason, William D., 1992: HPLC determination of m-hydroxymandelic acid and m-hydroxyphenylglycol in human plasma

YingXiXiang; LiHaiBo; ChuZhengYun; ZhaiYanJun; LengAiJing; LiuXun; XinChun; ZhangWenJie; KangTingGuo, 2008: HPLC determination of malondialdehyde in ECV304 cell culture medium for measuring the antioxidant effect of vitexin-4-O-glucoside

Venkateshwaran, T. G.; Stewart, J. T.; King, D. T., 1995: HPLC determination of morphine-ondansetron and meperidine-ondansetron mixtures in 09 percent sodium chloride injection

Lecompte, Suzanne; Dadgar, Darioush, 1993: HPLC determination of nicotinic acid and its metabolite, nicotinuric acid in urine following 500 mg niacin tablets in healthy adult males under fed and fasted conditions

Bulea,D.; Spac,A.; Dorneanu,V., 2008: HPLC determination of ochratoxin A in roasted coffee beans

Xu, Zi Shou; Miao, Jia Sheng, 1994: HPLC determination of ofloxacin tablets

Lozupone, A.; Micelli, G.; Quaranta, M.; Donadeo, A.; Lorusso, V., 1992: HPLC determination of oral lonidamine in ovarian cancer patients Preliminary results

Quintas,G.; Armenta,S.; Moros,J.; Garrigues,S.; Pastor,A.; Guardia,M.dela, 2008: HPLC determination of oxadiazon in commercial pesticide formulations

Gagliardi, L.; De Orsi, D.; Cavazzitti, G.; Tonelli, D.; Zappoli, Z., 1994: HPLC determination of oxiracetam, its impurities, and piracetam in pharmaceutical formulations

Zhang, Z. D.; Baeyens, W. R. G.; Zhang, X. R.; Van Der Weken, G., 1997: HPLC determination of penicillamine in human urine applying a chemiluminescent detection system

Wang-Mian; Tai-Yan; Li-Jing-Hong, 2008: HPLC determination of phenylacetic acid and penicillin G in 6-aminopenicillanic acid

LiuGao; RaoLiQun; FanShi; YangHua; PengGuoPing; LiLanLan; LongXiaoLei; ChenXi, 2008: HPLC determination of phyllanthin constituent in Phyllanthus urinari L

Lantz, Ronald J.; Knadler, Mary Pat, 1993: HPLC determination of raloxifene before and after hydrolysis of human plasma

Yang, Hong Wei, 1998: HPLC determination of ribavirin in troches

Koel, Marlies; Nebinger, Peter, 1994: HPLC determination of serum ganciclovir using ultrafiltration, ultraviolet and fluorescence detection

Zurek, T.; Lambiris, K.; Hariharan, S.; Miller, R.; Albert, K. S., 1993: HPLC determination of serum terodiline concentrations by UV detection

Jaaskelainen, Ilpo; Urtti, Arto, 1993: HPLC determination of some liposome components using evaporative light scattering detector

SuShuFang; ZhangMin; LiBaoLi; ZhangHaiYan; DongXiangChao, 2008: HPLC determination of sulfamethazine in milk using surface-imprinted silica synthesized with iniferter technique

Wang, Mao Yi; Yang, Ya Hui; Tian, Wei, 1994: HPLC determination of three components in compound indomethacin ointment

Palace, Vince P.; Brown, Scott B., 1994: HPLC determination of tocopherol, retinol, dehydroretinol and retinyl palmitate in tissues of Lake Char exposed to coplanar 3,3,4,45-pentachlorobiphenyl

Weng, N. D.; Mainquist, D.; Hulse, J. D.; Lee, J. W.; Kramer, W., 1994: HPLC determination of torsemide and three metabolites in human biological fluids

Rong, Hong Yang; Yu, Pei Zhong; Han, Rong Rong, 1998: HPLC determination of tramadol hydrochloride drops

Liu, Wei, 1995: HPLC determination of triamcinolone acetonide acetate and miconazole nitrate in Pikangshuang

Nishiyama Naruke A.J. A. Souza; Carnelos, M.; Curi, R., 1998: HPLC determination of underivatized fatty acids saponified at 37degreeC analysis of fatty acids in oils and tissues

De Orsi, D.; Gagliardi, L.; Turchetto, L.; Tonelli, D., 1998: HPLC determination of warfarin and acenocoumarol in raw materials and pharmaceuticals

Venkatewhwaran, T. G.; Stewart, J. T.; King, D. T., 1996: HPLC determinations of ondansetron with selected medications in 09 percent sodium chloride injection USP

Biava, Mariangela; Cirilli, Roberto; Fares, Vincenzo; Ferretti, Rosella; Gallinella, Bruno; La-Torre, Francesco; Poce, Giovanna; Porretta, Giulio-Cesare; Supino, Sibilla; Villani, Claudio, 2008: HPLC enantioseparation and absolute configuration of novel anti-inflammatory pyrrole derivatives

ZhangLi; WangYu, 2008: HPLC fingerprint analysis for Flos Daturae

Wu, S. T.; Stampfli, H. F.; Banks, C. M.; Emm, T. A.; Kapil, R. P.; Padovani, P. K.; LeeW. M.Jr.; Huang, S.M., 1993: HPLC fluorescence determination of XJ754, a IIb/IIa receptor antagonist, in biological fluids

Caldwell, D. J.; Manning, J. G.; Mcelroy, A. P.; Caldwell, D. Y.; Dean, C. E.; Hargis, B. M., 1995: HPLC fractionation of molecules from the bursa of Fabricius which inhibit B-lymphocyte proliferation Comparison with bursal anti-steroidogenic peptide

Lindner, Armando; Vanholder, Raymond; De Smet, R.; Hinds, Thomas; Ringoir, Severin, 1992: HPLC fractions of uremic plasma contain powerful inhibitor of the RBC calcium pump

Lewinski, M. A.; Bruce, S. K.; Peres, S. W.; Devor, K. A.; Porschen, R. K., 1998: HPLC identification of mycobacterial species isolated from the MB/BacT detection system

Stelzer, A.; Meusel, M.; Junghaenel, J.; Jira, T., 1996: HPLC investigations of chiral triazolophthalazines

Snyakin, A. P.; Shchukil', L. V.; Berlyand, A. S., 1994: HPLC measurement of phenosane acid in dosage forms

Allen, K. R.; Degg, T. J.; Rushworth, P. A.; Smith, M.; Henderson, M. J., 1998: HPLC measurement of phenylalanine and tyrosine in plasma

Newman, R. A.; Chen, W.; Madden, T., 1997: HPLC measurement of the novel non-nucleoside anti-HIV agent, -dihydrocalanolide A

Yamaguchi, Fumihide; Hatanaka, Chitoshi, 1993: HPLC measurement of the uronate and neutral sugar contents in corn hemicellulose

Hauck, Benjamin; Farrell, James, 1997: HPLC measurements of hydrophobic organic compound adsorption in water-saturated microporous materials

Walters, Denise Lowe; Jacobs, Deloria L.; Graves, Joseph E. Tomaszewski And Steven, 1995: HPLC method for analysis of various nucleosides in plasma using solid phase extraction and UV detection

Safgren, S. L.; Reid, J. M.; Buckner, J. C.; Rajkumar, S. V.; Rios, R.; Ames, M. M., 1997: HPLC method for and preliminary pharmacokinetics of the reactive metabolites of dacarbazine

WangJinJun; ZhangXiuMei; HuangZhaoWen, 2008: HPLC method for determination of four flavonoids in Rose Henryi Bouleng

Kallkova, Kveta; Tesarova, Eva; Bosakova, Zuzana, 2008: HPLC method for enantioselective analysis of cloprostenol

Murone, Michelangelo; Grazioli, Vittorio; Gaia, Paola; Casari, Erminia, 1995: HPLC method for separation and measurement of free and total fatty acids extracted from biological fluids and cellular membranes

Turner, Gregory; West, Nita; Skinner, Tim; Hallock, Yali; Vishnuvajjala, B. Rao, 1997: HPLC method for the analysis of KRN5500 and its impurities

El Shourbagy, Tawakol A. Roro; Hsu Beischer; Tames, Michelle M.; Sapochak, Lisa B.; Bauch, Joy; Marsh, Kennan; Chu, Sou Yie, 1996: HPLC method for the determination of A-86929 in human plasma using electrochemical detection

Hermes, Robert E.; Valdez, Lorene S., 1996: HPLC method for the determination of alkaloids in extracts of goldenseal

Lebel, Guy; Chin, Catherine; Forcione, Linda; Dadgar, Darioush, 1993: HPLC method for the determination of azathioprine , 6-mercaptopurine and 6-thiouric acid in human blood, for use in drug registration studies

Vallee, F.; Marcoux, M.J.; Bisson, C.; Lebel, M., 1997: HPLC method for the determination of diclofenac in human plasma

Lamparczyk, H.; Jankowski, A.; Zarzycki, P. K.; Nowakowska, J., 1994: HPLC method for the determination of estrogenic steroids in human urine

Vallee, F.; Marcoux, M.J.; Lebel, M., 1997: HPLC method for the determination of etodolac in human plasma

Vallee, F.; Bisson, C.; Lebel, M., 1997: HPLC method for the determination of famotidine in human plasma

Vallee, F.; Bisson, C.; Lebel, M., 1997: HPLC method for the determination of fluoxetine and norfluoxetine in human plasma

Vallee, F.; Bisson, C.; Lebel, M., 1997: HPLC method for the determination of indapamide in human blood

Vallee, F.; Bisson, C.; Lebel, M., 1997: HPLC method for the determination of labetalol in human plasma

Vallee, F.; Bisson, C.; Lebel, M., 1997: HPLC method for the determination of metformin in human plasma

Murthy, Satya S.; Owoo, George; Diegnan, Glenn, 1995: HPLC method for the determination of naltrexone, DELTA-7-nalmefene and 2,2-bisnalmefene impurities in nalmefene HCl

Babson, Bruce; Johnson, Richard; Roller, Tracy; Larke, Gregory, 1996: HPLC method for the determination of pentoxifylline and two of its major metabolites, hydroxypentifylline and carboxypropylpentifylline in human plasma

Macedo, I. Q.; Pires, E. V., 1996: HPLC method for the peptide mapping of KAPPA,alpha-s1- and beta-casein digested with a plant milk-clotting aspartic protease

Vyas, Renuka; Bell, Robert G.; Atwell, Stephen H., 1994: HPLC method for the simultaneous determination of acetaminophen, codeine phosphate, sodium benzoate and methylparaben in acetaminophen and codeine phosphate oral suspension

BikramjitSingh; Dikshit,A.K., 2008: HPLC method for thiacloprid residues in okra and tomato

Lau Cam, C. A.; Roos, R. W., 1994: HPLC method with dansylation for the assay of piperazine citrate in dosage forms

Atulkumar, Ramaiya; Karnes, H. Thomas, 1994: HPLC method with fluorescence detection for simultaneous quantitation of serotonin and paroxetine in rat brain microdialysate

Lau Cam, C. A.; Roos, R. W., 1997: HPLC method with spectrophotometric detection for the simultaneous assay of meglumine and its counterions iothalamic acid or diatrizoic acid in radiographic solutions for injection

Castro, R.; Reis, V.; Segurado, M. A. P.; Almeida, I. Tavares De, 1996: HPLC methodology for the determination of total plasma homocysteine Study of 53 patients with vascular disease

Lacroix, Pauline M.; Curran, Norman M.; Sears, Roger W., 1995: HPLC methods for ciprofloxacin hydrochloride and related compounds in raw materials

Lacroix, Pauline M.; Yat, Patrick N.; Lovering, Eward G., 1994: HPLC methods for fluoxetine hydrochloride, its meta isomer and related compounds in raw materials

Selsted, Michael E., 1997: HPLC methods for purification of antimicrobial peptides

Novakova, Lucie; Satinsky, Dalibor; Solich, Petr, 2008: HPLC methods for the determination of simvastatin and atorvastatin

Holman, G. Mark; Hayes, Timothy K., 1997: HPLC methods to isolate peptide neurotransmitters

Tomokuni, Katsumaro; Ichiba, Masayoshi; Hirai, Yukio, 1993: HPLC micro-method for determining delta-aminolevulinic acid in plasma

Vila,F.C.; Colombo,R.; Lira,T.O.de; Yariwake,J.H., 2008: HPLC microfractionation of flavones and antioxidant activity of Saccharum officinarum L

Abreu, O.; Mayell, J.; Palermo, P., 1997: HPLC mobile phase recycler equipment evaluation and validation

Betto, P.; Ricciarello, G.; Ruggeri, S.; Stocchi, F.; Baronti, F.; Nappi, G.; Martignoni, E.; Melzi D'eril, G. V.; Blandini, F.; Lucarelli, C., 1993: HPLC monitoring of plasma catechol levels in the characterization of Parkinsons disease

Croes, K.; Mccarthy, P. T.; Flanagan, R. J., 1995: HPLC of basic drugs and quaternary ammonium compounds on microparticulate strong cation-exchange materials using methanolic or aqueous methanol eluents containing an ionic modifier

Kazhoka, Kh A., 1995: HPLC of ftorafur and 5-fluorouracil on silica gel

Krauss, Gerd Joachim; Pissarek, Margit; Blasig, Ingolf, 1997: HPLC of nucleic acid components with volatile mobile phases part 2 Separations on polymeric supports

Kang, Tae Suk; Woo, Byung Ho; Lee, Jung Tae; Lee, Hye Suk; Deluca, Patrick P.; Lee, Kang Choon, 1995: HPLC of radioiodinated salmon calcitonins

Aitzetmueller, K., 1995: HPLC of triglycerides Identification of palm oils and palm oil fractions - Survey by a working party of the German society for fat science , 142nd report German standard methods for investigation of fats, fatty products, tensides and related materials, 109th report Analysis of fats XXXIII

Aitzetmueller, K., 1993: HPLC of triglycerides Survey by a working party of the DGF 136th report German standard methods for investigation of fats, fatty products, tensides, and related materials 103rd report Analysis of fats XXX

Thomas, Jim; Mort, Andrew, 1993: HPLC post-column reaction system for the detection of polysaccharides

Dowd, Michael, K.; Pelitire, Scott, M., 2008: HPLC preparation of the chiral forms of 6-methoxy-gossypol and 6,6 -dimethoxy-gossypol

Castro, R.; Reis, V.; Segurado, M. A. P.; Tavares De Almedia, I., 1998: HPLC procedure for total and free plasma homocysteine analysis

Kojima,K.; Ogihara,Y.; Sakai,Y.; Mizukami,H.; Nagatsu,A., 2008: HPLC profiling of Phellinus linteus

Hammack, B. N.; Butcher, L. M.; Dinh, H. T.; Saliman, J. A.; Campbell, C. H., 1994: HPLC protein analysis using C4 reverse phase column

Hill, J. C.; Flannery, G. M.; Fraser, B. A., 1994: HPLC purification and separation of 5,5-substituted-2,4-imidazolidinedithiones

Steinert, Juergen; Khalaf, Hosni; Rimpler, Manfred, 1995: HPLC separation and determination of naphtho furan-4,9-diones and related compound in extracts of Tabebuia avellanedae

Krenn, L.; Schlifelner, L.; Stimpfl, T.; Kopp, B., 1992: HPLC separation and quantitative determination of cardenolides in herba convallariae

Visich, Jennifer E.; Byron, Peter R., 1995: HPLC separation and radiochemical detection of thyrotropin-releasing hormone and its common metabolites in a physiologic salt solution circulated through the isolated perfused rat lung

Zimmerman, Jayne B.; Shuster, Judith E., 1993: HPLC separation of a basic pharmaceutical compound and potential impurities on a reversed-phase alumina column

Jira, T.; Vogt, Christiane; Blaschke, G.; Beyrich, T., 1993: HPLC separation of chiral benzol-1,4-diazepines

Emenhiser, C.; Schwartz, S. J.; Sander, L. C., 1994: HPLC separation of cis-trans carotenoids in human serum using a novel C-30 stationary phase

Sypniewska, R.; Wei, W. Z.; Mizukami, H.; Rosenspire, A., 1994: HPLC separation of distinct natural peptides isolated from MHC class I molecules on MMTV infected and noninfected cell lines of mammary epithelial origin

Cizmarik, J.; Lehotay, J.; Hromul'akova, K.; Pokorna, M.; Lacuska, M., 1997: HPLC separation of enantiomers of carbisocaine Study of local anaesthetics, part 138

Winkelamnn, Guenther; Cansier, Alexander; Beck, Werner; Jung, Guenther, 1994: HPLC separation of enterobactin and linear 2,3-dihydroxybenzoylserine derivatives A study on mutants of Escherichia coli defective in regulation , esterase and transport

Rice, Kevin G., 1996: HPLC separation of oligosaccharides from glycoproteins

Bi,F.; Arman,M.; Iqbal,S., 2008: HPLC separation of phytoalexins from Phaseolus vulgaris treated with elicitor from Colletotrichum lindemuthianum

Demetriou, Demetrios; Rustemeier, Klaus; Voncken, Peter; Schepers, Georg, 1993: HPLC separation of the enantiomers of nicotine and nicotine-like compounds

Palmieri, Margo, 1994: HPLC separation of the positional isomers of MDL 72,974A

Malhotra, S.; Phillips, M.; Becker, S. J., 1995: HPLC serum cortisol assay development and correlation to fluorescence polarization immunoassay

Shi, Robert; Yturralde, Oliva; Lin, Emil, 1995: HPLC simultaneous assay of gentamicin and paromomycin in human plasma-postcolumn derivatization

Guile, Geoffrey R.; Rudd, Pauline M.; Wing, David R.; Dwek, Raymond A., 1997: HPLC strategies for profiling and sequencing oligosaccharides

Hrobonova, K.; Lehotay, J.; Gazdikova, J.; Cizmarik, J., 1998: HPLC studies of the hydrolysis of carbisocaine enantiomers

Yushkova, E. I.; Danilenko, A. N.; Pavlovskaya, N. E.; Botuz, N. I., 2008: HPLC study of fulvic acids isolated from composts and vermicomposts of different origins

Fan, Jian Qiang; Kondo, Akihiro; Kato, Ikunoshin; Lee, Yuan C., 1993: HPLC with a graphitized carbon column Separation of chitooligosaccharides and glycopeptides

Matlin, Stephen A.; Tiritan, M. Elizabeth; Crawford, Andrew J.; Cass, Quezia B.; Boyd, Derek R., 1994: HPLC with carbohydrate carbamate chiral phases Influence of chiral phase structure on enantioselectivity

Mukherjee, Partha S.; Fariss, Marc W.; Karnes, H. Thomas, 1995: HPLC with laser induced fluorescence for the quantitation of gamma-cholesteryloxybutyric acid in rat liver tissue

Heinemann, U.; Blaschke, G.; Knebel, N. G.; Locher, M.; Engel, J., 1998: HPLC, LC-MS and CE analysis for the investigation of metabolism of the antiallergic/antiasthmatic agent azelastine

ZhangLiangLiang; LinYiMing, 2008: HPLC, NMR and MALDI-TOF MS analysis of condensed tannins from Lithocarpus glaber leaves with potent free radical scavenging activity

Zhang,W.; Han,F.; He,J.; Duan,C., 2008: HPLC-DAD-ESI-MS/MS analysis and antioxidant activities of nonanthocyanin phenolics in mulberry

Zhang, W.; Han, F.; He, J.; Duan, C., 2008: HPLC-DAD-ESI-MS/MS analysis and antioxidant activities of nonanthocyanin phenolics in mulberry Morus alba L

Wang, Dongmei; Lu, Jiali; Miao, Aiqing; Xie, Zhiyong; Yang, Depo, 2008: HPLC-DAD-ESI-MS/MS analysis in leaves of 22 tea of polyphenols and purine alkaloids cultivars in China

Arpini,S.; Fuzzati,N.; Giori,A.; Martino,E.; Mombelli,G.; Pagni,L.; Ramaschi,G., 2008: HPLC-DAD-MS fingerprint of Andrographis paniculata Nees

Brandsteterova, E.; Kubalec, P.; Skacani, I.; Balazovjech, I., 1994: HPLC-ED determination of catecholamines and their metabolites in urine

Julliard, J.; Maldiney, R.; Sotta, B.; Miginiac, E.; Kerhoas, L.; Einhorn, J., 1995: HPLC-ELISA and MS as complementary techniques to study plant hormone metabolites

Mistri, Hiren, N.; Jangid, Arvind, G.; Pudage, Ashutosh; Shrivastav, Pranav, 2008: HPLC-ESI-MS/MS validated method for simultaneous quantification of zopiclone and its metabolites, N-desmethyl zopiclone and zopiclone-N-oxide in human plasma

Mercolini, Laura; Saracino, Maria-Addolorata; Bugamelli, Francesca; Ferranti, Anna; Malaguti, Marco; Hrelia, Silvana; Raggi, Maria-Augusta, 2008: HPLC-F analysis of melatonin and resveratroll isomers in wine using an SPE procedure

Frame, Eileen M. Skelly, 1996: HPLC-ICP atomic emission spectrometry in environmental analysis

Bonkanka,C.X.; Smelcerovic,A.; Zuehlke,S.; Rabanal,R.M.; Spiteller,M.; Sanchez-Mateo,C.delC., 2008: HPLC-MS analysis and anti-oedematogenic activity of Hypericum grandifolium Choisy

Bonkanka, Celia, X.; Smelcerovic, Andrija; Zuehlke, Sebastian; Rabanal, Rosa-Maria; Spiteller, Michael; Sanchez-Mateo, Candelaria-Del-Carmen, 2008: HPLC-MS analysis and anti-oedematogenic activity of Hypericum grandifolium choisy Hypericaceae

Silvestro, L.; Savu, S. Rizea; Kinzig, M.; Soergel, F., 1995: HPLC-MS analysis of adducts between DNA nucleosides and cytotoxic platinum derivatives

Mueller, G.; Nickel, P.; Silvestro, L.; Savu, S. Rizea; Kinzig, M.; Soergel, F., 1995: HPLC-MS/MS characterization of suramin analogs

Silvestro, L.; Savu, S. Rizea; Bruno, M.; Kinzig, M.; Soergel, F., 1995: HPLC-MS/MS determination of GABA in brain microdialysis A pharmacologic application

Silvestro, L.; Kinzig, M.; Soergel, F.; Savu, S. Rizea; Maggi, T.; Terni, A.; Imbimbo, I., 1995: HPLC-MS/MS identification and quantification of heptylstigmine metabolites in human plasma and urine

Gutsche, B.; Herderich, M., 1998: HPLC-MS/MS identification of tryptophan-derived tetrahydro-beta-carboline derivatives in food

Saha, M.; Collins, L.; Switzer, S.; Harrison, B.; Marshall, C.; Gooding, R.; Gerdon, J.; Delgado, N., 1998: HPLC-MS/MS method for determination of tepraloxydim and its major metabolites in soil and sediment

Zomer, E.; Saul, S.; Quintana, J.; Charm, S. E., 1995: HPLC-Receptorgram A comprehensive method for identification of veterinary drugs and their active metabolites

Raju, Ch, B. V. N.; Panda, Gunanidhi; Rao, G. Nageswara; Rockey, Jose, 2008: HPLC-UV assay method for clindamycin palmitate hydrochloride as drug substance and oral solution

Saha, M.; Harrison, B.; Collins, L., 1998: HPLC-UV method for determination of tepraloxydim major metabolites in soil and sediment

Pav, Joseph W.; Rowland, Lois S.; Korpalski, Deborah J.; Elvin, Alfred T., 1997: HPLC-UV method for the quantitation of nevirapine in human plasma, serum, and milk following solid phase extraction

Staehler, M.; Buhr, Liselotte, 1996: HPLC-aided pigment analysis

Zhou, Qin; Bender, Eric M.; Song, Chun Qing; Ashendel, Curtis L.; Chang, Ching Jer, 1998: HPLC-assisted searching for potential antitumor agents for Crossosoma bigelovii

Royle, Louise; Campbell, Matthew, P.; Radcliffe, Catherine, M.; White, Dawn, M.; Harvey, David, J.; Abrahams, Jodie, L.; Kim, Yun-Gon; Henry, George, W.; Shadick, Nancy, A.; Weinblatt, Michael, E.; Lee, David, M.; Rudd, Pauline, M.; Dwek, Raymond, A., 2008: HPLC-based analysis of serum N-glycans on a 96-well plate platform with dedicated database software

Knudsen, T. B., 1997: HPLC-based mRNA differential display

Schmid, R. W.; Smekal, G., 1998: HPLC-determination of lamotrigine and hydroxy-carbazepine in serum by automated sample extraction using a restricted access precolumn

Becker Scharfenkamp, U.; Blaschke, G., 1993: HPLC-determination of the analgesic drug etodolac and its metabolites in proband urine as well as stereoselective determination of its main metabolites

Hensley, K.; Maidt, L.; Anderson, Robert E.; Wack, M.; Floyd, R. A., 1997: HPLC-electrochemical array detection of protein oxidation and nitration products in CNS tissue

Lohmann, C.; Wilhelm, C., 1997: HPLC-fingerprinting as a quantitative method to estimate phytoplankton assemblages in waters of different trophic state

Allgire, James; Toler, Duckhee, 1992: HPLC-fluorescence method for albuterol in metered dose inhalers

Payne, Lori D.; Wehner, Teresa A.; Norton, Jack A.; Dunbar, Dennis M., 1998: HPLC-fluorescence method to determine the residue to emamectin benzoate and its 8,9-Z isomer on soil

Wu, S. T.; Banks, C. M.; Creveling, J.; Huang, S.M., 1995: HPLC-fluorometric determination of XL843 in dog plasma

Izquierdo Hornillos, R.; Shepard, T. A., 1993: HPLC-isocratic study of the separation and determination of phenolphthalein and its metabolite, phenolphthalein-glucuronic acid, as markers of enterohepatic circulation

Van Hoek, A. N.; Wiener, M. C.; Bicknese, S.; Biwersi, J.; Miercke, L.; Stroud, R. M.; Verkman, A. S., 1993: HPLC-purification of functional CHIP28 water channels for determination of secondary structure by CD and FTIR spectroscopy

Koerdel, Werner; Stutte, Joerg; Kotthoff, Gisela, 1995: HPLC-screening method to determine the adsorption coefficient in soil-comparison of immobilized humic acid and clay phases for cyanopropyl columns

Naylor, P. H.; Nandi, P. S.; Revannasiddappa, V. B.; Shahzad, S. M.; Siddiqui, F.; Reddy, S.; Naylor, C. W., 1995: HPLC-solid phase ELISA demonstrates the present of both prothymosin alpha and thymosin alpha-1 in normal peripheral blood lymphocytes and CEM T cell lymphoma cells

Abidi, S. L., 1993: HPLC-thermospray-mass spectrometric analysis of piscicidal toxicants

Timoteo,P.; Karioti,A.; Leitao,S.G.; Vincieri,F.F.; Bilia,A.R., 2008: HPLC/DAD/ESI-MS analysis of non-volatile constituents of three Brazilian chemotypes of Lippia alba N E Brown

Sanaullah, Mohammed Jemal, 1997: HPLC/ESMS investigation of pH-dependent stability and acyl migration of an acylglucuronide in aqueous solutions

Segarra, Ignacio; Floren, Leslie C.; Napoli, Kim L.; Kahan, Barry D.; Benet, Leslie Z.; Christians, Uwe, 1997: HPLC/MS method for simultaneous determination of sirolimus and cyclosporine in blood samples

Waters, R. K.; Watt, R. A., 1997: HPLC/NMR determination of the rate of 5-aminolevulinic acid decomposition and identification of breakdown products in intravenous formulation media

Kane, Maureen, A.; Folias, Alexandra, E.; Napoli, Joseph, L., 2008: HPLC/UV quantitation of retinal, retinol, and retinyl esters in serum and tissues

Jordan, Candace R.; Dashek, William V.; Highley, Terry L., 1994: HPLC/colorimetric oxalic acid quantification and ESI localizations of P, C and Fe from Postia placenta grown on agar or wood blocks in liquid culture

Shiah, J.G.; Spikes, J. D.; Sun, Y.; Kopeckova, P.; Peterson, C. M.; Kopecek, J., 1998: HPMA copolymer bound meso-chlorin e6 in combination therapy of experimental ovarian carcinoma

Gianasi, E.; Evagorou, E.; Buckley, R. G.; Kneller, S.; Malik, N.; Wilson, G.; Duncan, R., 1998: HPMA copolymer platinates as novel anti-cancer agents

Caiolfa, V. R.; Frigerio, E.; Castelli, M. G.; Poggesi, I.; Fiorino, A.; Marsiglio, A.; Lovisolo, P. P.; Farao, M.; Sola, F.; Pesenti, E.; Zamai, M.; Angelucci, F.; Suarato, A., 1998: HPMA-based tumor delivery Pharmacokinetics and antitumor activity of the first MAG-phe-leu-gly-CPT soluble derivative

Rajabi Siahboomi, A. R.; Bowtell, R. W.; Mansfield, P.; Davies, M. C.; Melia, C. D., 1993: HPMC hydrophilic matrix systems Effect of degree of substitution on swelling behaviour and water mobility

Rajabi Siahboomi, A. R.; Henderson, A.; Davies, M. C.; Melia, C. D., 1993: HPMC hydrophilic matrix systems Structure-activity relationships and release behaviour of diclofenac sodium

Sriwongjanya, M.; Bodmeier, R., 1996: HPMC tablet containing ion exchange resins

Naesens, L.; Snoeck, R.; Andrei, G.; Balzarini, J.; Neyts, J.; De Clercq, E., 1997: HPMPC , PMEA and related acyclic nucleoside phosphonate analogues A review of their pharmacology and clinical potential in the treatment of viral infections

Kessler, H.; Kapell, K.; Pottage, J.; Benson, C.; Sha, B., 1993: HPMPC, trifluridine and foscarnet activity in vitro against acyclovir resistant and sensitive HSV isolates from patients with AIDS

Casciola Rosen, L.; Pluta, A.; Plotz, P.; Nagaraju, K.; Cox, A.; Morris, S.; Rosen, A., 1998: HPMS1 is a novel, frequently targeted myositis autoantigen which is cleaved by granzyme B but not by caspases during apoptosis

Finette, B. A.; Poseno, T.; Forman, E.; Dickerman, J. D.; Homans, A. C., 1996: HPRT T-lymphocyte assay monitoring of chemotherapeutic toxicity in pediatric oncology patients

Mironov, N.; Zhu, W.B.; Aguelon, A.M.; Yamasaki, H., 1997: HPRT gene mutation and expression of DNA-repair gene ERCC1 in replication error positive cells after exposure to carcinogen

Cole, J.; Beare, D. M.; Aldrich, K. A.; Green, M. H. L., 1993: HPRT mutant frequency in circulating T-lymphocytes in normal and at risk groups in the human population

Hempel, K.; Leuner, K.; Lorenz, R., 1992: HPRT mutation frequency in T-lymphocytes from mice irradiated in vivo Role of dose rate, radiation quality and survival time

Albertini, R. J., 1998: HPRT mutations in human T-cells as probes for fundamental cellular and molecular processes

Cannons, Jennifer Leigh; Karsh, Jacob; Birnboim, H. Chaim; Goldstein, Rose, 1998: HPRT- mutant T cells in the peripheral blood and synovial tissue of patients with rheumatoid arthritis

Yano, Nozomi; Matsuura, Shinya; Endo, Satoru; Tauchi, Hiroshi; Komatsu, Kenshi, 1996: HPRT-mutation of Chinese hamster irs1SF cells belonging to XRCC3 and the involvement of a human chromosome 14 for the restoration of radiation resistance

Gathof, B. S.; Rocchigiani, M.; Micheli, V.; Gaigl, Z.; Gresser, U., 1998: HPRT-mutations in Italian Lesch-Nyhan patients

Sangar, R. B. S.; Upadhya, M. D., 1993: HPS-7/13 A promising TPS hybrid for potato production in northern hills of Chhattisgarh-MP

Forssmann, W G.; Herbst, F.; Schulz Knappe, P.; Adermann, K.; Gagelmann, M., 1998: HPTH-fragment- , the preparation thereof, medicaments containing same and the use thereof

Hedrera, Monica E.; Perillo, Isabel A.; Fernandez, Beatriz M., 1995: HPTLC A complementary successful method for the elucidation of organic reaction mechanisms Cyclic amidines

Vega, Mario; Garcia, Graciela; Saelzer, Roberto; Villegas, R., 1994: HPTLC Analysis of Antibiotics in Fish Feed

Agbaba, D.; Lazarevic, R.; Zivanov Stakic, D.; Vladimirov, S., 1995: HPTLC Assay of acetylsalicylic acid and the impurity salicylic acid in pharmaceuticals

Mody, Vandana D.; Patel, Ramanbhai B.; Chakravarthy, Balkrishna, 1994: HPTLC Detection and Determination of Clobetasol Propionate in Topical Cream

Wagner, Jurgen; Jork, Hellmuk; Koglin, Eckhard, 1993: HPTLC as a reference method in clinical chemistry On-line coupling with spectroscopic methods

Agbaba, D.; Eric, S.; Stakic, D. Zivanov; Vladimirov, S., 1998: HPTLC assay of cephalexin and cefaclor in pharmaceuticals

Orinak, Andrej; Gyoryova, Katarina; Lancaricova, Sylvia, 1993: HPTLC characterization of newly synthesized zinc coordination compounds

Vampa, G.; Benvenuti, S.; Melegari, M., 1992: HPTLC determination of ascorbic acid in fruits of the genera Ribes, Rubus, and Vaccinium

Sparzak, Barbara; Krauze-Baranowska, Miroslawa; Poblocka-Olech, Loretta, 2008: HPTLC determination of catechins in in-vitro cultures of two species of the genus Phyllanthus

Pisternick, Wendelgard; Guendisch, Daniela; Kovar, Karl Artur, 1996: HPTLC discrimination of 3,4-methylenedioxyamphetamines of the ecstasy group using o-benzenesulfonamido-p-benzoquinone as detection reagent

Sankaranarayanan, Jayashri; Khanapure, Virendra M.; Jolly, Chungath I., 1993: HPTLC fingerprint analysis of Momordica charantia, Curcuma longa, Emblica officinalis, and their mixtures

Rodrigo, Gabriela A.; Bekerman, Diana G.; Renou, Sergio G.; Abasolo, M. A. Ines; Fernandez, Beatriz M., 1995: HPTLC for monitoring the kinetics of formation of quinoxaline derivatives 2 Benzoquinoxalinone derivatives

Agbaba, Danica; Grozdanovic, Olivera; Popovic, Ljubica; Vladimirov, Sote; Zivanov Stakic, Dobrila, 1996: HPTLC in the quantitative assay of drugs

Mirakor, Vijay; Vaidya, Vikas; Menon, Sasikumar; Champanerker, Parikshit; Laud, Avdhoot, 2008: HPTLC method for determination of colchicine in a pharmaceutical formulation


Submit PDF Full Text

No spam - Every submission is manually reviewed

Due to poor quality, we do not accept files from Researchgate

Submitted PDF Full Texts will always be free for everyone
(We only charge for PDFs that we need to acquire)

Select a PDF file:
Close
Close